basic principle of chemotherapy by saeid kashefi
DESCRIPTION
Basic principle of chemotherapy for pharmacy student.TRANSCRIPT
SAEID KASHEFI Page 1
Pharmacology
II
Chemotherapy
I. General Chemotherapy 1) Basic principle of chemotherapy …………………………………………….……3
2) Sulphonamides, trimethoprim ……………………………………………….……15
3) Quinolones, urinary antiseptics ………………………………………….….……19
4) β-lactam antibiotics…………………………………………………………………23
5) Aminoglycosides……………………………………………………………………30
6) Tetracyclines ……………………………………………………………………….36
7) Chloramphenicol …………………………………………………………….……..41
8) Macrolides …………………………………………………………………….……43
9) Miscellaneous agents ……………………………………………………….……48
II. Specific Chemotherapy 1) TB ……………………………………………………………………………………53
2) Leprosy………………………………………………… …………………………..58
3) Antiviral ……………………………………………………………………………..60
4) Antifungal …………………………………………………………………………...67
5) Antiprotozoal………………………………………………………………………..75
Antiamebic ………………………………………………………………..75
Antimalarial ……………………………………………………………….72
6) Anthelmintics ………………………………………………………………………..82
6) Anticancer ……………………………………………………………………….…86
2012-2013
SAEID KASHEFI Page 2
Basic principle of
Chemotherapy
SAEID KASHEFI Page 3
1) Classify the antibiotics based on their mechanism of action. Describe the mechanism of action
of each group of drugs? (10)
Different ways of Classification
1. Chemical Structure
2. Mechanism of action
3. Type of organisms
against which it is active
4. Spectrum of activity
5. Type of action
6. Source of the antibiotic
Classification I: Chemical Structure
Sulfonamides Diaminopyridines Quinolones β lactams Tetracycline Imidazoles
Dapsone
Sulfamethoxazole
PAS
Trimethoprim
Pyrimethamine
Nalidixic acid
Ciprofloxacin
Penicillins
Cephalosporins
Monobactams
Doxycycline
Minocycline
Miconazole
Clotrimazole
Aminoglycosides Macrolides Polypeptides Nitrofurans Nitroimidazoles Miscellaneous
Streptomycin
Gentamycin
Paromomycin
Amikacin
Neomycin
Erythromycin
Clarithromycin
Azithromycin
Roxithromycin
Polymyxin-B
colistin
Bacitracin
Nitrofurantoin
Furazolidone
Metronidazole
Tinidazole
Rifampicin
Vancomycin
Griseofulvin
Ethambutol
Clofazimine
Chloramphenicol
Classification II: Mechanism of Action
Inhibits Cell wall
synthesis
Inhibits protein
synthesis
Inhibits DNA
synthesis
Inhibits DNA
gyrase
β lactams
Vancomycin
Bacitracin
Cycloserine
Tetracyclines
Chloramphenicol
Clindamycin
Idoxuridine
Acyclovir
Zidovudine
Metronidazole
Iodoquinol
Quinolones
Inhibits intermediary
metabolism
Interferes with DNA
function
Cause Leakage of Cell
membranes
Misreads m-RNA
sulfonamides
PAS
Trimethoprim
Ethambutol
Rifampicin
Metronidazole
Polymyxins
Colistin
Bacitracin
Amphotericin B
Nystatin
Hamycin
Aminoglycosides
SAEID KASHEFI Page 4
Classification III: Type of Microbe affected
Antibacterial Antifungal Antiviral Antiprotozoal Anthelmintic
penicillins,
aminoglycosides
Griseofulvin
Amphotericin
Idoxuridine
Acyclovir
Amantadine
Chloroquine
Pyrimethamine
Mebendazole
Pyrantel
DEC
Classification IV: Spectrum of activity
Narrow Spectrum Broad Spectrum
Penicillin G,
Streptomycin,
Erythromycin
Tetracycline,
Chloramphenicol
Classification V: Type of Action
Primarily Bacteriostatic Primarily Bactericidal
Sulfonamides
Macrolides
Erythromycin
Clindamycin
Tetracycline
Chloramphenicol
Ethambutol
Nitrofurantoin
Novobiocin
Trimethoprim
Penicillin
Cephalosporins
Aminoglycosides
Vancomycin
Bacitracin
Metronidazole
Polymixin
Pyrazinamide
Quinolones
Rifampicin
Isoniazid
Co-trimoxazole
Classification VI: Source
Fungal Bacteria Actinomycetes
Penicillin,
Cephalosporin
Griseofulvin
Polymyxin,
Colistin,
Aztreonam
Aminoglycosides,
Tetracyclines,
Chloramphenicol
Macrolides
SAEID KASHEFI Page 5
Mechanism of action of certain antibiotics
Agent Example Mechanism of Action / Notes
Aminoglycosides streptomycin neomycin
Inhibit protein synthesis by binding to a portion of the bacterial ribosome. Most of them are bacteriocidal (cause bacterial cell death).
Bacitracin Inhibits cell wall production by blocking a step in the process (recycling of the membrane lipid carrier) which is needed to add on new cell wall subunits.
β-lactam antibiotics
penicillins cephalosporins carbapenems monobactams
Group of antiobiotics which contain a specific chemical structure (a beta-lactam ring)
Cephalosporins Similar to penicillins in their mode of action, but they treat a broader range of bacterial infections. The have structural similarities to penicillins and many people with allergies to penicillins also have allergic reactions to cephalosporins.
Chloramphenicol Inhibits protein synthesis by binding to a subunit of bacterial ribosomes (50S).
Glycopeptides vancomycin Interferes with cell wall development by blocking the attachment of new cell wall subunits (muramyl pentapeptides).
Macrolides erythromycin Inhibit protein synthesis by binding to a subunit of the bacterial ribosome (50S).
Lincosamides clindamycin Inhibit protein synthesis by binding to a subunit of the bacterial ribosome (50S).
Penicillins Inhibit formation of the bacterial cell wall by blocking cross-linking of the cell wall structure. The cell wall is a needed protective casing for the bacterial cell wall.
Quinolones Block DNA synthesis by inhibiting one of the enzymes (DNA gyrase) needed in this process.
Rifampin Inhibits RNA synthesis by inhibiting one of the enzymes (DNA-dependent RNA polymerase) needed in this process. RNA is needed to make proteins.
Tetracyclines Inhibit protein synthesis by binding to the subunit of the bacterial ribosome (30S subunit).
Trimethoprim and Sulfonamides
Blocks cell metabolism by inhibiting enzymes which are needed in the biosynthesis of folic acid which is a necessary cell compound.
SAEID KASHEFI Page 6
Buy AT 30 and SELL at 50
30 S 50S
Aminoglycosides
Tetracyclines
Streptogramines
Erythromycin
Lincosamides
Linezolide
SAEID KASHEFI Page 7
2) Explain the difference between broad spectrum and narrow spectrum antibiotics. Give
examples? (2)
An antibiotic may be classified as "narrow-spectrum" or "broad-spectrum" depending on the range of bacterial
types that it affects.
1) Narrow-spectrum antibiotics are active against a select group of bacterial types.
A narrow-spectrum antibiotic acts only against specific families of bacteria.
2) Broad-spectrum antibiotics are active against a wider number of bacterial types and, thus, may be used to treat a
variety of infectious diseases.
Broad-spectrum antibiotics are particularly useful when the infecting agent (bacteria) is unknown.
A broad-spectrum antibiotic acts against many different kinds of disease-causing bacteria, including both
gram-positive and gram-negative bacteria.
Narrow Spectrum Broad Spectrum
Penicillin G,
Streptomycin,
Erythromycin
Tetracycline,
Chloramphenicol
SAEID KASHEFI Page 8
3) What are the limitations of antimicrobial agents? Explain, giving suitable example, the various
way in which microbes acquire resistance? (4+8)
Problems of Chemotherapy
1) Toxicity : a] Local & b] Systemic
2) Hypersensitivity
3) Nutritional deficiency
4) Masking of Infections
5) Drug Resistance
6) Superinfection
Local irritancy Systemic toxicity
Local: Irritation
At site of administration
Gastric irritation, pain
Pain, abcess at site of im
injection.
Thrombophlebitis
Most antimicrobials are irritant
Especially see:. Erythromycin,
tetracyclines, some cephalosporins,
chloramphenicol
Most AMA have systemic toxicity
Safe
Penicillin, Cephalosporins [some] Erythromycin Safe even at 100 times therapeutic dose
Moderately toxic
Aminoglycosides 8th cranial nerve, Nephrotoxicity Tetracyclines Liver & kidney damage
Chloramphenicol bone marrow depression
Very toxic
Polymyxin B neurological & kidney toxicity Vancomycin hearing loss & Nephrotoxicity Amphotericin kidney, bone marrow, neurological
toxicity
2. Hypersensitivity
Most AMAs cause hypersensitivity
Most frequent penicillins, cephalosporins, sulfonamides
3. Nutritional factors,
Nutritional deficiency
↓B complex group, Vitamin K synthesis by microflora
Neomycin malabsorption syndrome
4. Masking of infection
Eg short course of streptomycin masks tuberculosis
SAEID KASHEFI Page 9
5. Drug Resistance
Naturally resistant:
gram –ve resistant to penicillin
clinically insignificant
Acquired resistance:
Occurs on prolonged exposure to the AMA
Important Clinical problem
Depends on both AMA & microbe
Some microbes are more prone Eg tubercle bacteria, staphylococci
Some less prone: Strep pyogenes still sensitive to penicillin
Gonococci rapidly developed resistance to sulfonamides but slowly to penicillin
Mechanisms of drug resistance
[1] Mutation (single & multistep) [2] Gene transfer Conjugation
1. Mutation :
spontaneous, heritable genetic change
Resistant mutants proliferate selectively
Single step: a single mutation confers resistance: RAPID
Eg Enterococci to streptomycin
E coli & Staphylococci to rifampicin
Multistep: stepwise graded decrease in sensitivity: Slow
Many organisms develop gradual resistance to erythromycin, tetracycline, chloramphenicol
2. Gene transfer Mechanisms
[1] Conjugation, [2] Transduction, [3] Transformation
Conjugation Transduction Transformation
an important mode of resistance
Transfer of DNA (chromosomal or
plasmid) carrying resistance gene
Occurs through the sex pili during
conjugation
More common among gram –ve
Occurs more in colon, rich in
microflora
Sometimes from nonpathogenic to
pathogenic microbes
Gene transfer through a
bacteriophage
R factor enters virus,
delivered to infected
bacterium
Occurs in penicillin,
erythromycin,
chloramphenicol
R factor from a resistant
bacterium enters the medium
Picked up a nonresistant
bacterium
Rare eg pneumococcal
resistance to penicillin G
SAEID KASHEFI Page 10
Nature of Resistance
1) Drug tolerant
loss of AMA target
Eg. Staph aureus, E coli with RNA polymerase that does not bind rifampicin
Altered metabolic pathway
Eg. Sulfonamide resistant bacteria switch to using preformed folic acid instead of synthesising it
2) Drug destroying
β lactamase destroyed by Staphylococci, Haemophilus, Gonococci
Aminoglycosides are acetylated, phosphorylated etc.
3) Drug Impermeable
Hydrophilic AMAs enter through porins
Eg. chloroquine resistant falciparum do not take up drug
4) Cross Resistance
Defn: Resistance to one AMA confers resistance to a closely related AMA
Total cross resistance Partial cross
resistance
Two way One way
Sulfonamides &
Tetracyclines : resistance
to one means resistance
to all
Resistance to
gentamycin but not
amikacin
erythromycin
Clindamycin two way
Neomycin resistance
leads to streptomycin
resistance
Not vice versa
6. Super infection
Appearance of a new infection when treating another
Intestinal microflora inhibit pathogens
Microflora compete with pathogens for nutrition
Killing microflora normally nonpathogenic components of microflora Eg Candida proliferate becomes
pathogenic
Prolonged use of broad spectrum kills microflora superinfection
Eg tetracycline, chloramphenicol >> amoxicillin
More when combinations are used
More when host immunity is compromised
Eg. corticosteroids, immunosuppressants, diabetes
Site of superinfections : oropharynx, intestinal, respiratory, genitourinary tracts [ Loci harboring commensals]
Superinfections more difficult to treat
Common superinfections
Candida albicans diarrhoea, thrush, vulvovaginitis
Staphylococci enteritis
Clostridium difficile pseudomembranous enterocolitis
SAEID KASHEFI Page 11
4) Outline the important factors that affect the choice of an antimicrobial agent in therapeutics? (7)
Factors influencing the choice of an AMA
1) Patient factors 2) Drug factors 3) Infecting Organism Factors
Patient Factors Drug factors
1) Age
2) Renal/ Hepatic function
3) Drug Allergy
4) Site of infection
5) Pregnancy
6) Genetic factors
7) Impaired host defence
1) Spectrum of activity
2) Type of activity Cidal Vs Static
3) Sensitivity of organism [MIC ; post antibiotic effect]
4) Relative toxicity [Choose less toxic one Eg penicillin]
5) pharmacokinetics
6) route of administration
7) evidence of clinical efficacy
8) cost
A) Patient Factors
1) Age
Conjugation & excretion of chloramphenicol in new born gray baby syndrome [ emesis, hypotonic,
hypothermic, irregular respiration, ashen gray cyanosis, cardiovascular collapse, death]
Sulfonamides displace bilirubin from protein binding sites kernicterus in neonates [ poor BBB]
↑T ½ of aminoglycosides in elderly ↑ VIII cranial nerve toxicity
Tetracycline accumulates in growing teeth discolored teeth in children < 6 yr
2) Impaired Renal function
To be used with caution Aminoglycosides, Cephalosporins, Vancomycin, Ethambutol
To be avoided Cephalothin, nitrofurantoin, nalidixic acid, tetracycline
Impaired Hepatic function
To be used with caution [ reduce doses] Chloramphenicol, INH, Metronidazole, Rifampin
To be avoided Erythromycin, pyrazinamide, tetracyclines, Pefloxacin
3) Drug Allergy
most frequently caused by beta lactams, sulfonamides, fluoroquinolones, nitrofurantoin
4) Pregnancy
Better to avoid because of risk to fetus
Tetracycline, aminoglycosides, fluoroquinolones, chloramphenicol
5) Genetic Factors
Primaquine, nitrofurantoin, sulfonamides, chloramphenicol hemolysis in G6PD deficiency
SAEID KASHEFI Page 12
6) Site of infection
Pus decreases action of aminoglycosides & sulfonamides Necrotic material delays healing ; nearly impossible
Hematomas
Promote bacterial growth
Penicillin, cephalosporin, tetracyclines bind to degraded hemoglobin
Lowering of pH reduce aminoglycoside & macrolides
Anaerobic environment aminoglycosides don‘t act in the centre of abcess
Barriers: Ophthalmic, prostatic, SABE, etc Some drugs don‘t penetrate barriers
7) Impaired host defense [Neutropenia, AIDS]
Cidal drugs needed
Intensive therapy complete eradication
Reserve drugs
B) Drug factors
1) Spectrum of activity :
Narrow spectrum better [ but limited by diagnostic accuracy! ]
But broad spectrum for empirical therapy
2) Type of activity Cidal Vs. Static
Cidal >>Static especially in immunocompromised, severe cases
Less accessible bec of a barrier --SABE
3) Sensitivity of organism [MIC ; post antibiotic effect]
4) Relative toxicity [Choose less toxic one Eg penicillin]
5) Pharmacokinetics
Most antibiotics given at 2-4 T ½ attain effective conc intermittently
Concentration dependent inhibition Action depends on peak conc Eg aminoglycosides
Single doses better than divided doses
Time dependent inhibition: Penicillins
Action based on time conc is maintained > MIC
Divided doses better
Penetration
Quinolones tissue penetration
Ceftrioxone, Ciprofloxacin CSF penetration
6) Route
Oral for less severe cases Parenteral for severe cases, Eg septicemia, meningitis
7) Evidence of clinical efficacy
Clinical evidence most important! Reliable clinical trial data
8) Cost
SAEID KASHEFI Page 13
5) Explain with example any 5 indications of chemo-phylaxis? (5)
1. Prophylaxis against specific organisms In general highly satisfactory; the choice of drug is clearcut.
(a) Rheumatic fever: group A Streptococci: long acting penicillin G is the drug of choice for preventing
recurrences.
(b) Tuberculosis: Children, HIV positive and other susceptible contacts of open cases: Isoniazid alone or with
rifampin is recommended.
(c) Mycobacterium avium complex (MAC): HIV/ AIDS patients with low CD4 count may be protected against
MAC infection by azithromycin/ clarithromycin.
(d) HIV infection: Health care workers exposed to blood by needle stick injury: zidovudine + lamivudine +
indinavir. Offspring of HlV positive woman can be protected by zidovudine given to pregnant mother and then to
the newborn for 6 weeks.
(e) Meningococcal meningitis: during an epidemic, especially in contacts; rifampin/ sulfadiazine / ceftriaxone
may be used.
(f) Gonorrhoeae /syphilis: before or immediately after contact: ampicillin/ceftriaxone.
(g) Recurrent genital herpes simplex: Acyclovir prophylaxis may be given when four or more recurrences occur
in a year.
(h) Malaria: for travellers to endemic areas with high transmission rate: chloroquine/mefloquine.
(i) Influenza A2: during an epidemic, especially in contacts: amantadine.
(g) Cholera: tetracycline prophylaxis may be given to close contacts of a case.
(k) Whooping cough: non-immunized child contact during the incubation period: erythromycin can abort clinical
disease.
(1) Plague: contacts curing an epidemic: doxycycline.
2. Prevention of infection in high risk situations it may be valid and satisfactory in certain situations, but
controversial in others.
(a) Dental extraction, tonsillectomy, endoscopies cause damage to mucosa harbouring bacteria bacteremia
occurs. In patients with valvular defects, this can cause endocarditis: appropriate prophylaxis with amoxicillin or
clindamycin may be given few hours before to few hours after the manipulation.
(b) Catheterization or instrumentation of urinary tract: cotrimoxazole or norfloxacin. Patients with valvular
lesions may be protected with ampicillin, gentamicin or vancomycin during catheterization.
(c) To prevent recurrences of urinary tract infection in patients with abnormalities of the tract:
cotrimoxazole or nitrofurantoin may be given on a long-term basis since the organism mostly is E. coll.
(d) Chronic obstructive lung disease, chronic bronchitis: ampicillin /doxycycline/ ciprofloxacin has been used
to prevent acute exacerbations: but are of doubtful value.
(e) Immunocompromised patients (receiving corticosteroids or antineoplastic chemotherapy, neutropenic
patients): penicillin/cephalosporin an aminoglycoside or fluoroquinolone are often used to prevent respiratory
tract infections and septicaemiae, but incidence of superinfections is high.
3. Prevention of infection in general this is highly unsatisfactory in most cases and must be condemned.
(a) Neonates, especially after prolonged or instrumental delivery.
(b) To prevent postpartum infections in the mother after normal delivery.
(c) Viral upper respiratory tract infections: to prevent secondary bacterial invasion.
SAEID KASHEFI Page 14
6) Give the advantages of antimicrobial combination with example? (2)
Advantages Disadvantages
1) Synergism
2) Reduce ADR
3) Prevent resistance
4) Broaden spectrum
1) Promote a casual outlook in diagnosis / choice of AMA
2) Increase incidence of ADRs
3) Increase superinfections
4) Emergence of resistant organisms in inadequate doses
5) Increased cost
6) Antagonistic combinations Eg Penicillin + Tetracycline
A. Synergism
1 Additive
A. Bacteriostatic + Bacteriostatic
B. Tetracycline+ Chloramphenicol
2. Supra additive
A. Co-trimoxazole (cidal effect)
B. Bactericidal + Bactericidal
Penicillin + Aminoglycoside
INH+ Rifampin
B. Reduces ADRs
Combinations help reduce dose ↓ ADRs
Eg Streptomycin + Penicillin G in bacterial endocarditis
C. Reduces emergence of resistance
INH + Rifampin + Pyrazinamide in Tuberculosis
D. Broaden spectrum
Useful in severe infections, mixed infections
SAEID KASHEFI Page 15
Sulphonamide
SAEID KASHEFI Page 16
7) Explain how cotrimoxazole acts as a synergistic combination? (2)
8) Explain the rational of the combination cotrimoxazole in chemotherapy? (4)
9) Explain how cotrimoxazole acts as synergistic combination? (2)
10) Describe the mechanism of sequential blockade in antimicrobial action with subtile
examples? (4)
Individually, both sulfonamide and trimethoprim are bacteriostatic, but the combination becomes cidal against
many organisms.
Maximum synergism is seen when the organism is sensitive to both the components, but even when it is
moderately resistant to one component, the action of the other may be enhanced.
Combination of Sulphonamide with trimethoprim (5:1 gives 20:1 Cp)
Trimethoprim + Sulphamethoxazole PABA
Similar t1/2 (11 and 10h)
Sequential inhibition of enzymatic pathway
Synergistic combination
Sequential Blockade
Pteridine Dihydropteroic acid (Inhibited by
Sulphonamide)
Dihydrofolic acid Tetrahydrofolic acid (Inhibited
by trimethoprim)
Bacteriostatic effect to bactericidal
SAEID KASHEFI Page 17
Special purpose:
Sulfacetamide Silver Sulfadiazine Sulfasalazine Sulfadoxine
Sulfacetamide (eye) ? As eye drops & ointment
High aqueous solubility
Neutral pH and non-irritant nature of the drug
Good penetrability on topical administration
Low incidence of hypersensitivity reactions
Low cost
Silver Sulfadiazine topical for
preventing infections of burn
wounds. Silver slowly release
silver ions which are toxic to
microorganism, not effective in
the presence of pus and tissue
fluids
Sulfasalazine
colon (ulcerative
colitis)
Sulfadoxine
resistant
falciparum
(with
pyrimetham
ine)
Adverse effect of Sulfonamides
(ABC of Rash)
Pharmacogenetic Variation in Drug
response due to enzyme deficiency
Drug interactions
A- Aplastic anemia
B- Bilirubin displacement
(Kernicterus)
C- Crystalluria
R-Rash
A-Acetylation
S-SLE
H-Hemolysis of G-6-PD
deficiency
Glucose -6-phosphate dehydrogenase deficiency
American Negros, Mediterranes Jews, Middle East and South East races – deficient in G6PD
Responsible for supply of NADP ---acts as cofactor for glutathion reductase
NADP---oxidised glutathion to reduced gutathion-------convertes Fe+++ to Fe++ in hemoglobin---also stability to RBC
Oxidising drugs Primaquine, Sulfone, nitrofurantoin----hemolytic anaemia
Potentiate the action of
Sulphonylureas
Oral anticoagulants
Hydantoins
By inhibition of metabolism
and/OR
Displacement from protein
binding
SAEID KASHEFI Page 18
11) Why is sulphacetamide preferred to other sulpha drugs for ophthalmic use? (2)
Sulfacetamide sodium it is a highly soluble compound yielding neutral solution which is only mildly irritating to the
eye in concentrations up to 30%.
It is used topically for ocular infections due to susceptible bacteria
It attains high concentrations in anterior segment and aqueous humour after topical instillation.
The incidence of sensitivity reactions with ocular use of sulfacetamide sodium has been low; but it must be
promptly stopped when they occur.
SAEID KASHEFI Page 19
Quinolones
SAEID KASHEFI Page 20
12) Classify fluoroquinolones with examples.
Describe their MOA. Compare and contrast norfloxacin with ciprofloxacin.
Why are fluoroquinolones not given to people under the age of 18 years? (2+3+2+1)
13) Describe the antimicrobial spectrum and mechanism of action of fluoro-quinolones.
Enumerate their therapeutic uses and adverse effect? (2+2+2+2)
14) Compare and contrast ciprofloxacin and levofloxacin? (5)
examples Uses Pharmacokinetics
FIRST Gram -ve
Norfloxacin
Ciprofloxacin,
Ofloxacin,
Pefloxacin,
Lomefloxacin
Urinary tract
infections
Gonorrhoea
Chancroid
Gastroenteritis
Typhoid Bone and soft tissue
infections
Respiratory
Tuberculosis
Gram –ve
septicaemias
Meningitis
Oral bioavailability- 80 to 95%
Wide distribution – tissues and
fluids
Half-life: 3 h (Nor- and
Ciprofloxacin)
– 10 h (Pefloxacin), t1/2 >10 h
(Spar- and Levofloxacin)
++ cations interfere with
absorption
Renal elimination (GF and TS)
Adverse effects Drug Interactions
Second Gram +ve
Gram –Ve
Levofloxacin
Prulifloxacin
GIT- nausea,
vomiting, diarrhoea
Headache,
dizziness, insomnia,
rashes
Acute hepatitis,
hepatic failure
(Trovafloxacin)
Photosensitivity-
QTc interval
prolongation
Damage to
growing cartilage
Ciprofloxacin, Grepafloxacin
and Pefloxacin inhibit
Theophylline, warfarin
metabolism
NSAIDs with Fluoroquinolones
CNS stimulation
Seizures
Third Gram +ve Gatifloxacin
Sparfloxacin
Gemifloxacin
Gram +ve
+ Anaerobes
Moxafloxacin
Trovafloxacin
Alatrofloxacin
Finafloxacin
SAEID KASHEFI Page 21
Mechanism of action
Inhibition of DNA gyrase
– Prevents relaxation of positively supercoiled DNA
Topoisomerase IV
– Interferes with separation of replicated chromosomal DNA
MOA Kinetics ADR Uses
Pefloxacin Methyl derivative of
norfloxacin
Higher Lipid
solubility
Cumulates in
plasma, Higher
Cp
Dose reduction in
liver disease
Meningeal infections
Ofloxacin More potent than
cipro for G+ve
No interference
from food
Dose reduction in
Renal failure
Urethritis
Cervicitis
Atypical pneumonia,
leprosy
Levofloxacin Higher activity
against G +ve
No drug interactions
with theophylline
100% oral
bioavailability
Very useful in
pneumonia,
bronchitis, sinusitis,
pyelonephritis
Once daily dosing
Sparfloxacin Difluorinated
quinolone
Very effective
against G +ve, B.
fragilis, Mycobacteria
Phototoxicity
Prolongation of QT
interval
Should not be given
along with
o Cisapride
o TCAs
o Phenothiazines
o Class I and III
antiarrhythmics
Pneumonia, chronic
bronchitis, sinusitis,
TB and leprosy
Single dose per day
Gatifloxacin Highly effective
against Strep.
pneumoniae,
anaerobes
Prolongation of QT
interval
Phototoxicity and
CNS effects
Pneumonia, chronic
bronchitis, UTI
gonorrhoea
One dose per day
Moxafloxacin High activity against
beta lactam and
macrolide resistant
streptococci
May precipitate
seizures
Prolongs QT
interval
Useful in pneumonia,
bronchitis, otitis
media, sinusitis
Single daily dose
SAEID KASHEFI Page 22
15) Why cisapride avoided in patient taken sparfloxacin? (2)
It has caused a higher incidence of phototoxic reactions: recipients should be cautioned not to go out in the sun.
Slight prolongation of QTc interval has been noted in 3% recipients; should be avoided in patients taking
cisapride, tricyclic antidepressants, phenothiazines, class IA and class III antiarrhythmics, etc.
Sparfloxacin metabolized in liver by glucuronidation and hase longer t1/2 (18-20).
Because of longer t1/2 it is suitable for single daily dosing.
(Cisapride is CYP3AP enzyme inhibitor)
sparfloxacin Should not be given along with
– Cisapride
– TCAs
– Phenothiazines
– Class I and III antiarrhythmics
SAEID KASHEFI Page 23
β-lactams
Penicillin
Cephalosporin
SAEID KASHEFI Page 24
16) Classify penicillins with examples. Describe their mechanism of action of its two penicillins
used pseudomonas infection? (5+3+2)
Antipseudomonal Penicillin
Carbenicillin
Not active orally
IM or IV
ADRs: Fluid retention, Bleeding
Uses: Burns, UTI, Septicemias
Natural Penicillins Penicillin G
Semi-Synthetic
Acid-resistant phenoxymethyl Penicillin (Penicillin V)
Penicillinase-
resistant
Methicillin, Cloxacillin, Dicloxacillin, Nafcillin, Oxacillin, Flucloxacillin
Amino-penicillins Ampicillin, Amoxacillin ( Broad spectrum drugs, susceptible to
penicillinase, orally effective)
Antipseudomonal
(Carboxypenicillin)
Carbenicillin, Ticarcillin, Azlocillin, Piperacillin
( Broad spectrum drugs, susceptible to penicillinase, Poor oral absorption )
Ureidopenicillins Mezlocillin, Piperacillin
B-lactamase
inhibitors
Clavulanic acid, Sulbactam, Tazobactam
Reverse spectrum Pivmecillinam ( Effective against Gram negative organisms )
SAEID KASHEFI Page 25
17) Describe with a neat diagram the biosynthesis of bacterial cell wall. Explain the mechanism of
action of drugs that inhibit the process involved in wall synthesis? (8)
Mechanism of action of Penicillins-
Inhibition of Bacterial Cell Wall Synthesis
- Inhibition of transpeptidation cause:
Cross linking absent
Cell wall deficient forms
burst under osmotic pressure
Peptidoglycan cause mechanical stability
Gram +ve 50-100—thick,
Gram –ve 1-2 thick
Peptidoglycan
Glycon chains-liner stand of two alternative amino
sugar
NAG-N-acetyl glycosamine
NAMA-N-acetyl muramic acid
Cross linked by peptide chains
Involves 30 bacterial enzymes
Peptidoglycan contains 3 stages:
1) Precursor formation
2) Formation building block
3) Completion of cross link
NAG-N-acetyl glycosamine
NAMA-N-acetyl muramic acid
1. NAMA-NAG
2. L-alanine
3. D-GLUTAMINE
4. L-lysine--------------- (glycine) 5
5. D-alanine
6. D-alanine
Uridine diphosphate (UDP)-acetyl muramyl-penta-
peptide
Alanine racemase-racemization of L-alanine
D-alanyl-D-alanine synthetase
Transpeptidase
SAEID KASHEFI Page 26
Mechanism of action of penicillins
1. All β-lactams inhibit cell wall synthesis
2. Cell wall is a cross linked peptidoglycan polymer
3. Polysaccharides crosslinked with pentapeptide
4. Polysaccharide alternate N acetyl glucosamine + N acetyl muramic acid
• Penicillin binds to proteins [PBP] that catalyse the transpeptidase reaction which cross links the
Polysaccharide with peptide
• This occurs in dividing cells only
• Faulty cell wall osmotic lysis bactericidal
• Gram +ve cell walls have peptidoglycan but –ve have alternate layers of lipoproteins also present
• More active on gram +ve
SAEID KASHEFI Page 27
18) With a diagram describe the mechanisms of action of 3 drugs which inhibit bacterial cell wall
synthesis at different stages? Mention the draw backs of penicillin G? (6+2)
Cycloserine Vancomycin Bacitracin Β-lactam
Is a chemical analogue of
D-alanine
Inhibits bacterial cell wall
synthesis by inactivating
the enzymes which
racemize l-alanine an link
2 D-alanine residue
Binds to terminal
dipeptide sequence
of peptidoglycan unit
prevents its release
from carrier
inhibits cell wall
synthesis,
Bactericidal
It acts by inhibiting cell wall synthesis at a step
earlier than that inhibited by penicillin.
It increases the efflux of ions by binding to cell
membrane.
Bactericidal.
Penicillin binds to proteins
[PBP] that catalyses the
transpeptidase reaction
which cross links the
Polysaccharide with
peptide
This occurs in dividing cells
only
Faulty cell wall
osmotic lysis
Bactericidal
Limitation/Drawbacks of PnG
1. Orally not very effective (acid labile)
2. Short duration of action
3. Narrow spectrum of antibacterial activity
4. Destroyed by penicillinase enzyme
5. Possibility of anaphylaxis
So semisynthetic penicillin have been developed
SAEID KASHEFI Page 28
19) Why is penicillin-G ineffective against gram –ve organism? List the therapeutic use and
adverse effect of penicillin-G? (2+4)
Antibacterial Spectrum of Penicillin G
PnG is a narrow spectrum antibiotic; activiiy is limited primarily to gram-positive bacteria and few others.
Cocci- Bacilli
Streptococci, Pneumococci,
―Staphylococci‖ (G +ve)
Neisseria (G –ve)
only G +ve sensitive
Bacillus anthracis
Corynebacterium diphtheriae
Listeria
Spirochaetes
• Poor entry of drug (G –ve bacteria)
• Porin channels
• Penicillin G –Uses
Uses
Streptococcal infections
Pharyngitis, otitis media, scarlet fever,
rheumatic fever
Sub-acute bacterial endocarditis (SABE)
Penicillin G (10-20 MU, IV, d)+
Streptomycin (0.5g IM X 2/d)
Pneumococcal infections Pneumonia & Meningitis (IV Penicillin G, 3-5 MU 6h)
Meningococcal infections Meningitis (IV Penicillin G, High doses)
Gonorrhoeae Not reliable
Syphilis Procaine Penicillin G X 10 days
Diphtheria & Tetanus As an adjuvant to Antitoxin
Prophylactic uses Rheumatic fever
Gonorrhoea
Adverse effect:
1) One of the most nontoxic; up to 60 g no direct toxicity
2) Local irritation pain, thrombophlebitis
3) Hypersensitivity incidence 1 – 10%[major ]
Most common allergenic drug [ test dose of 2-10 U is a must]
Common itching, rash, fever, wheezing, exofoliative dermatitis, angioedema
Rare [ 1-4 per 10000] anapylaxis
Allergy more in parenteral routes
Limited cross sensitivity between penicillins/ Topical use completely avoided because of high risk
SAEID KASHEFI Page 29
20) Cephalosporins? (4)
21) Compare and contrast 1st generation of CEPHALOSPORINS with the 3rd generation? (2)
Source: Cephalosporium acremonium
Oral Parental β- lactamase
enzyme
B.B.B. Uses
1st
Cephalexin
Cephaloridine
Cefadroxil
Cephradine
Cefazolin
Cephalothin
Cephapirin
Gram +Ve= +++
Gram -Ve = +
CSF penetration: Poor (+)
Not effective against Salmonella,
Shigella, Pseudomonas and
B.fragilis
Susceptible to B-lactamases
(exception: Cephalothin)
Cephalothin is
highly resistant
to
Staphylococcal
BLE
Does not
cross BBB
Skin
soft tissue infection,
Surgical Prophylaxis
(Cefazolin- long duration
action)
2nd
Cefuroxime
Cefaclor
axetil
Loracarbef
Cefprozil
Cefoxitin
Cefuroxime
Cefotetan
Cefmetazole
Ceforanide
Cefonicid
Cefamandole
against Gram +Ve= ++
against Gram -Ve = ++
CSF penetration: Good (++)
Resistant to Gram –Ve B-
lactamases
Not effective against
Pseudomonas and B.fragilis
(exception: Cefoxitin)
Less active than First generation
drugs against Gram +Ve Cocci
Cefoxitin &
cefuroxime are
resistant to
BLE
Some
(Cefuroxime)
cross the
BBB --- reach
CSF
Anaerobic infection
(Cefoxitin and cefotetan-
abdominal and pelvic
infection
RTI- Oral Cephalosporins
3rd
Cefixime
Ceftibuten
Cefdinir
Cefpodoxime
Cefditoren
Ceftriaxone
Ceftizoxime
Ceftazidime
Cefoperazone
Cefotaxime
Moxalactam
against Gram +Ve= +
against Gram -Ve = +++
CSF penetration: Very Good
(+++)
Highly resistant to Gr-Ve B-
lactamases
Ceftazidime has max
anti-pseudomonal action
Cefotaxime toxic to aerobic
organisms
Ceftriaxone has long duration of
action
Most of them
highly resistant
to most of BLE
(except
Cefoperazone)
Most of them
cross BBB-
high con in
CSF (
Cefotaxime,
ceftriaxone)
Gram –Ve infection
Urinary, RTI,
Soft tissue infection
Thyphoid fever
Meningitis
Mixied aerobic and
anaerobic
Penicillinase producing
S. Aureus infection
Gonococcal infection
Septicaemia, Nosocomial
infection
4th
Cefepime
Cefpirome
Cefozopran
Cefepime:
Properties similar to III
generation
with enhanced B-lactamases
resistant activity and CSF
penetration property
Effective against Streptococci
and Staph
Not effective against MRSA
Used against serious Gram-Ve
infections like hospital acquired
pneumonia, febrile neutropenia,
bacteremia, etc.,
Cefpirome:
Zwitterion, thus, better
penetration
Resistant to many B-
lactamases
More potent than III
generation drugs against
Gram +Ve and some Gram-
Ve organisms
Useful against many serious
infections including
septicaemias, LRT infections
5th Ceftobiprole
Ceftaroline
SAEID KASHEFI Page 30
Aminoglycoside
SAEID KASHEFI Page 31
22) List out the common properties of aminoglycosides antibiotics. Describe the mechanism of
action of aminoglycosides antibiotics. Describe how these drugs cause ototoxicity? (3+3+2)
Common properties:
1) All are used as sulfate salts, which are highly water soluble; solutions are stable for months.
2) All are active primarily against aerobic gram negative bacilli and do not inhibit anaerobes.
3) All, exhibit ototoxicity and nephrotoxicity.
4) All are bactericidal and more active at alkaline pH.
5) All are excreted unchanged in urine by glomerular: filtration
6) They ionize in solution are not absorbed orally; distribute only extracellularly; do not pentetate brain or CSF
7) They act by interfering with bacterial protein synthesis.
8) There is only partial cross resistance among them.
9) They have relatively narrow margin of safety.
Mechanism of action
The aminoglycosides are bactericidal antibiotics,
All having the same general pattern of action which may be described in two main steps:
(a) Transport of the aminoglycoside through the bacterial cell wall and cytoplasmic membrane.
(b) Binding to ribosomes resulting in inhibition of protein synthesis.
Transport of aminoglycoside into bacteria is a multistep process.
They diffuse across the outer coat of gram-negative bacteria through porin channels.
Penetration is dependent upon maintenance of a polarized membrane and on oxygen dependent active
processes. These processes are inactivated under anaerobic conditions; anaerobes are not sensitive and
facultative anaerobes are more resistant when O2 supply is deficient .eg. Inside big abscesses. Penetration is
also favored by high pH; aminoglycosides are -20 times more active in alkaline than in acidic medium.
Inhibitors of bacterial cell wall (β-lactams, vancomycin) enhance entry of aminoglycosides and exhibit
synergism.
Once inside the bacterial cell, streptomycin binds to 30S ribosomes, but other aminoglycosides bind to
additional sites on 50S subunit, as well as to 30S-50S interface.
They freeze initiation of protein synthesis prevent polysome formation
Binding of aminoglycoside to 30S-50S juncture causes distortion of mRNA codon recognition resulting in
misreading of the code: one or more wrong amino acids are entered in the peptide chain and or peptides of
abnormal lengths are produced.
The cidal action of these drugs appears to be based on secondary changes in the integrity of bacterial cell
membrane, because other antibiotics which inhibit protein synthesis (tetracyclines, chloramphenicol,
erythromycin) are only static.
The cidal action of aminoglycosides is concentration dependent, i.e. rate of bacterial cell killing is directly related
to the ratio of the peak antibiotic concentration to the MIC value.
They also exert a long and concentration dependent 'post-antibiotic effect'
SAEID KASHEFI Page 32
It has, therefore, been argued that despite their short t1/2 ( 24hr), single injection of the total daily dose of
aminoglycoside may be more effective and possibly less toxic than its conventional division into 2-3 doses
Ototoxicity:
Vestibular (partially reversible) or the cochlear (irreversible) part maybe primarily affected by a particular
aminoglycoside.
These Drugs are concentrated in the labyrinthine fluid and are slowly removed from it when the plasma
concentration falls.
Aminoglycoside ear drops can cause ototoxicity when instilled in patients with perforated eardrum;
contraindicated in them.
[ Ototoxicity is damage to the ear (oto-), specifically the cochlea or auditory nerve and sometimes the vestibular system, by
a toxin. It is commonly medication-induced; ototoxic drugs include
Antibiotics such as the aminoglycoside gentamicin,
loop diuretics such as furosemide,
platinum-based chemotherapy agents such as cisplatin.
NSAIDS such as Meloxicam have also been shown to be ototoxic.
Either may be reversible and temporary, or irreversible and permanent.]
Mechanisms of resistance
Resistance to aminoglycosides is acquired by one of the following mechanisms:
1) Acquisition of cell membrane bound inactivating enzymes which
Phosphorylate/ adenylate / acetylate the antibiotic.
2) through Mutation;
E.Coli to streptomycin
3) By altering transporting mechanism
Pseudomonas
4) By altering receptor protein structure
SAEID KASHEFI Page 33
23) Discuss the major adverse reactions of aminoglycoside? (2)
PRECAUTIONSA ND INTERACTIONS
1) Avoid aminoglycosides during pregnancy: risk of foetal ototoxicity.
2) Avoid concurrent use of other ototoxic drugs, e.g. high ceiling diuretics, minocycline.
3) Avoid concurrent use of other nephrotoxic drugs, e.g. amphotericin B, vancomycin, cyclosporine and cisplatin.
4) Cautious use in patients past middle age and in those with kidney damage.
5) Cautious use of muscle relaxants in patients receiving an aminoglycoside.
6) Do not mix aminoglycoside with any drug in the same syringe/infusion bottle.
24) Aminoglycosides lose their antibacterial activity in acidic environment? (2)
Penetration is also favored by high pH; aminoglycosides are -20 times more active in alkaline than in acidic
medium
25) Why are aminoglycosides bacterial unlike other protein synthesis inhibitors? (2)
The cidal action of aminoglycosides drugs appears to be based on secondary changes in the integrity of bacterial
cell membrane, because other antibiotics which inhibit protein synthesis (tetracyclines, chloramphenicol,
erythromycin) are only static.
26) Write briefly on Gentamycin? (5)
• Most commonly used aminoglycoside for acute gram –ve bacillary infections
• More potent than strepto, similar kinetics
• broader spectrum; kills P areuginosa, ineffective on M tuberculosis,
• cheapest, common first line drug in
– acute respiratory infections in immunocompromised critical patients,
– burns, UTI, pneumonia, -ve bacterial meningitis
– SABE with penicillins
• More nephrotoxic than strepto
– Requires dose adjustment in renal failure
Methicillin resistant staphylococci
SAEID KASHEFI Page 34
27) Differences between Gentamycin and streptomycin? (2 )
Gentamycin streptomycin
• Most commonly used aminoglycoside for
acute gram –ve bacillary infections
• More potent than strepto, similar kinetics
• broader spectrum; kills P aeruginosa,
ineffective on M tuberculosis,
• cheapest, common first line drug; in
– acute respiratory infections in
immunocompromised critical patients,
– burns, UTI, pneumonia, -ve bacterial
meningitis
– SABE with penicillins
• More nephrotoxic than strepto
– Requires dose adjustment in renal failure
• Strepto~: Oldest; relatively narrow spectrum
– Presently used in tuberculosis only
• Resistance:
– via plasmid, rapid esp in GIT & UTI;
– Resistance in GIT and UT emerge in 2 days!
– Some become dependent on streptomycin for translation
– E coli, H influenzae, Strep, Staph aureus mostly resistant,
– M tuberculosis develop rapid resistance if used alone
– Partial cross resistance with other aminoglycosides
• Kinetics:
– Ionized, unabsorbed by GIT;
– im injn a must ; stays in ECF; vol of distrib [0.3 /kg]
– Conc in CSF subtherapeutic, even in meningitis
– Excreted unchanged in urine by GFR; T ½ = 2-4 hr
• ADRs:
– Vestibular damage >> auditory ;
– least nephrotoxic aminoglycoside
– low superinfection
28) How dose bacterial resistances occur to the aminoglycoside antibiotics? (3)
Mechanisms of resistance
Resistance to aminoglycosides is acquired by one of the following mechanisms:
1) Acquisition of cell membrane bound inactivating enzymes which
Phosphorylate/ adenylate / acetylate the antibiotic.
5) through Mutation;
E.Coli to streptomycin
6) By altering transporting mechanism
Pseudomonas
7) By altering receptor protein structure
SAEID KASHEFI Page 35
29) Write briefly on Neomycin? (2)
30) Give reasons for the use of Neomycin in hepatic coma? (2)
Obtained from S. Fradiae
Active against most gram negative bacilli and some gram-positive cocci
Neomycin is highly toxic to the intimal ear (mainly auditory) and to kidney. It is, therefore, not used
systemically. Absorption from the G.I.T. is minimal.
Oral and topical administration does not ordinarily cause systemic toxicity.
Uses
1. Topically (often in combination with polymyxin, bacitracin, etc.) for infected wound, ulcers, burn, external ear
infections, conjunctivitis, but like other topical anti-infective preparations, benefits are limited.
2. Orally for:
(a) Preparation of bowel before surgery:
(3 doses of 1.0 g along with metronidazole 0.5 g on day before surgery) may reduce postoperative infections.
(b) Hepatic coma:
Normally NH3 is produced by colonic bacteria. This is absorbed and converted to urea by liver. In severe
hepatic failure, detoxication of NH3 does not occur; blood NH3 levels rise and produce encephalopathy.
Neomycin, by suppressing intestinal flora, diminishes NH3 production and lowers its blood level; clinical
improvement is seen within 2-3 days. However, because of toxic potential it is infrequently used for this
purpose; lactulose is preferred.
Adverse effects
Applied topically neomycin has low sensitizing potential. However, rashes do occur.
Oral neomycin has a damaging effect on intestinal villi-prolonged treatment can induce malabsorption
syndrome with diarrhoea and steatorrhea. It can decrease the absorption of digoxin and many other drugs, as
well as bile acids.
Due to marked su
ppression of gut flora, superinfection by Candida can occur.
Small amounts that are absorbed from the gut or topical sites are excreted unchanged by kidney.
This may accumulate in patients with renal insufficiency-cause further kidney damage and ototoxicity.
Neomycin is contraindicated if renal function is impaired.
Applied to serous cavities (peritoneum), it can cause apnoea due to muscle paralysing action.
SAEID KASHEFI Page 36
Tetracyclines
SAEID KASHEFI Page 37
31) List the major differences between old and newer TETRACYCLINES?
Drugs
Route
of
admin.
Absorption
from the
gut (%)
t1/2
hour
dosage Intestinal
absorption
Elimination Photo-
toxicity
Group I
short acting
Older
tetracyclines
Tetracycline
Chlortetracycline
Oxytetracycline
Oral
i.v
topical
30-60 6-12 250-500
mg q.i.d
Moderate Rapid renal
excretion
Low
Group II
intermediate
acting
Second
generation
Demeclocycline
Methacycline
Oral 60-80 6-12 300-600
mg b.d
Moderate Partial metabolism, slower renal
excretion
Highest
Group III
long acting
Highly
potent drug
Doxycyline
Minocycline
(Dox < mino)
Oral
i.v
95-100
16-24
100 mg
b.d or
o.d
Complete, no interference by food
Doxy: Primarily excreted in faces as conjugate Mino: Primarily metabolized, excreted in
urine and
bile
Doxy:
High
Liver damage Fatty infiltration of liver and jaundice occurs occasionally. Oxytetracycline and tetracycline are
safer in this regard.
All tetracyclines, except doxycycline, accumulate and enhance renal failure.
Phototoxicity a higher incidence has been noted with demeclocycline and doxycycline
Diabetes insipidus Demeclocycline antagonizes ADH action and reduces urine concentrating ability of the
kidney.
Vestibular toxicity Minocycline has produced ataxia, vertigo and nystagmus, which subside when the drug is
discontinued.
Superinfection it is common with older tetracyclines because of their incomplete absorption in the gut.
Doxycycline and minocycline are less liable to cause diarrhoea, because only small amounts reach the lower
bowel in the active form
SAEID KASHEFI Page 38
32) Enumerate TETRACYCLINES and mention their adverse effects? (2)
33) Adverse effect of oxytetracycline? (2)
drugs Adverse effect
Group I
Short acting
Older tetracyclines
Tetracycline
Chlortetracycline
Oxytetracycline
1) On GIT
Nausea, vomiting, diarrhoea
Direct local irritation
Suprainfections
Suppression of normal flora
Overgrowth of resistant ones
2) Bone structures and teeth
Bound to Ca in newly formed bone or teeth
Fluorescence, discoloration and enamel dysplasia (fetal teeth)
Bone deformity & growth inhibition
3) Liver
Ingestion of ―out-dated‖ tetracyclines cause ―Fanconi-like‖
syndrome
4) Kidney
5) Photosensitization
Demeclocycline, Doxycycline (in fair skinned)
6) Vestibular reactions
Dizziness, vertigo, nausea, vomiting
Doxycycline >100mg
Minocycline 200-400mg/d
7) Jarish- Herxheimer reaction: sudden rise of fever, rigors,
hypertension, hyperventilation
Group II
Intermediate acting
Second generation
Demeclocycline
Methacycline
Group III
long acting
Highly potent drug
Doxycyline
Minocycline
(Dox <
mino)
34) Which TETRACYCLINES are drug of choice in patient with renal impairment and why? (2)
Kidney damage it is prominent only in the presence of existing kidney disease.
All tetracyclines, except doxycycline, accumulate and enhance renal failure.
A reversible Fanconi syndrome like condition is produced by outdated tetracyclines due to proximal tubular
damage caused by degraded products-
Epitetracycline,
Anhydrotetracycline
Epianhydrotetracycline.
Exposure to acidic pH, moisture and heat favours such degradation.
SAEID KASHEFI Page 39
35) Tetracyclines are contraindicated in children below 12 years? (2)
Tetracyclines have chelating property. Calcium-tetracycline chelate gets deposited in developing teeth and
bone.
Given from mid pregnancy to 5 months of extrauterine life, the deciduous teeth are affected: brown
discoloration, ill-formed teeth, more susceptible to caries.
Tetracyclines given between 3 months and 6 years of age affect the crown of permanent anterior dentition.
Repeated courses are more damaging.
Given during late pregnancy or childhood, tetracyclines can cause temporary suppression of bone growth.
The ultimate effect on stature is mostly insignificant, but deformities and reduction in height are a possibility
with prolonged use.
36) Mention the drug interaction of tetracyclines? (2)
1) Al3+
, Ca2+
, Zn2+
, Mg2+ and iron preparations decrease tetracycline absorption by chelation.
2) Tetracyclines may reduce insulin requirements and may alter lithium blood levels.
3) Tetarcyclines inhibit intestinal flora that produces vitamin K, and therefore may potentiate the anticogulant
effects of warfarin.
4) Enzyme inducers such as barbiturates, phenytoin and carbamazepine reduce serum levels of tetracyclines.
SAEID KASHEFI Page 40
37) Describe the mechanism of action of TETRACYCLINES. How do bacteria develop resistance
to tetracyclines? (4)
Mechanism of action
The tetracyclines are primarily bacteriostatic; inhibit protein synthesis by binding to 30S ribosomes in susceptible
organism.
Subsequent to such binding, attachment: of aminoacyl-t-RNA to the mRNA-ribosome Complex is interfered with.
As a result the peptide chain fails to grow.
The sensitive organisms have an energy dependent active transport process which concentrates tetracyclines
intracellularly. In gram negative bacteria tetracyclines diffuse through porin channels as well. The more lipid-
soluble members (doxycycline, minocycline) enter by passive diffusion also (this is partly responsible for their
higher potency).
The carrier involved in active transport of tetracyclines is absent in the host cells. Moreover, protein synthesizing
apparatus of host cells is less sensitive to tetracyclines. These two factors are responsible for the selective
toxicity of tetracyclines for the microbes.
1) Aminoglycosides bind to several sites at 30S and 50S subunits as well as to their interface-freeze initiation
interfere with polysome formation and cause misreading of mRNA codon
2) Tetracyclines binds to 30S ribosome and inhibit aminoacyl tRNA attachment to the A site
3) Chloramphenicol binds to 50S subunit-interfere with peptide bon formation and transfer of peptide chain from
P site
4) Erythromycin and clindamycin also bind lo 50S ribosome and hinder the translocation of elongated peptide
chain back from A site to P site and the ribosome does not move along the mRNA to expose the next codon.
Resistance
1) Nearly complete cross resistance is seen among different members of the tetracycline group
2) Partial cross resistance between tetracyclines and chloramphenicol has been noted.
3) Plasmid mediated synthesis of a 'protection' protein which protects the ribosomal binding site from
tetracycline.
SAEID KASHEFI Page 41
CHLORAMPHENICOL
SAEID KASHEFI Page 42
38) Mechanism of action, uses of CHLORAMPHENICOL and their toxic effect? (2)
MOA
Chloramphenicol acts primarily by binding
reversibly to the 50 S ribosomal subunit.
Prevents the binding of the amino-acid-
containing end of the aminoacyl tRNA to the
acceptor site on the 50 S ribosomal subunit.
Interaction between peptidyl transferase and
its amino acid substrate cannot occur, and
peptide bond formation is inhibited
In eukaryotes, inhibits mitochondrial 70s
ribosomes→ host toxicity
Erythropoietic cells very sensitive
Resistance Therapeutic uses Adverse effects Drug interactions
Inactivation by
acetyltransferase
Acetyl derivative
fails to bind to
ribosomes
Decreased
permeability
(E coli,
pseudomonas)
Mutation
Typhoid fever (1g QID
X 4 weeks)
Bacterial meningitis
Anaerobic infections
Rickettsial infections
Brucellosis
Bone marrow depression
Hypersensitivity reactions
Irritative effects
Superinfections
Gray baby syndrome
Inhibition of Cytochrome
p450 leads to prolongation of
t1/2 of
o Warfarin
o Dicumarol
o Phenytoin
o Chlorpropamide
o Protease inhibitors
Kinetics
Absorbed rapidly orally
Well distributed even to CSF
50% plasma protein binding
Bile, milk , crosses placenta , aqueous humor
Hepatic metabolism
39) Why are the Erythropoietic cells very sensitive to chloramphenicol? (2)
At high doses, it can inhibit mammalian mitochondrial protein synthesis as well. Bone marrow cells are especially
susceptible.
SAEID KASHEFI Page 43
Macrolides
SAEID KASHEFI Page 44
40) Uses and adverse effects of Erythromycin? (2)
Erythromycin (prototype)
Streptomyces erythreus
Bacteriostatic at low & bactericidal at high concentration
Concentrated intracellularly by active transport
More active in alkaline medium
Mechanism of Action
Inhibits bacterial protein synthesis
Binds to 50s ribosomal subunit
Interferes with ‗translocation‘ of nascent peptide chain from A
site to P site
Premature termination of protein synthesis
Highly active against:
Strep. pyogenes, Strep. pneumoniae, N. gonorrhoeae
Clostridia, Listeria, Legionella
Cornybacterium diphtheriae, Campylobacter
Mycoplasma
Cross resistance with other macrolides, clindamycin,
chloramphenicol
Adverse Effects
G.I.T. stimulates motilin receptors-epigastric pain
Hearing impairment (Reversible)
Hypersensitivity
Hepatitis with estolate ester
SAEID KASHEFI Page 45
Interactions
Enzyme inhibitor
↑ plasma levels of theophylline, carbamazepine, valproate, ergotamine, warfarin, terfenadine, astemizole.
7- E
1) Erthromycin
2) Enteric coated tablets
3) Enterohepatic cycling
4) Erythromycin Estolate
5) Enteranal toxicity mainly
6) Epigastric pain
7) Enzyme inhibitors
Uses
As alternative to penicillin As first choice drug in As second choice drug
1. Streptococcal infections:
Tonsillitis, pharyngitis,
cellulitis, pneumonia
2. Diphtheria
3. Tetanus
4. Syphilis & gonorrhoea
1. Mycoplasma pneumoniae
2. Whooping cough (Pertussis)
3. Chancroid
1. Campylobacter enteritis
(fluoroquinolones)
2. Legionnaire‘s pneumonia
(azithromycin/ ciprofloxacin)
3. Chlamydia trachomatis (azithromycin)
4. Penicillin resistant staphylcoccal
infections
Mnemonic-MLCDPTS
(Uses of Erythromycin)
Mycoplasma Pnemoniae infections
Legionnaire‘s pneumonia
Chlamydial infections
Diphtheria
Pertussis
Tetanus
Streptococcal infection
Prophylatic uses
SAEID KASHEFI Page 46
41) Write briefly on newer macrolides as antibacterial agents? (4)
Newer Macrolides
1. Clarithromycin
2. Azithromycin
3. Roxithromycin
Adverse Effects Uses
Clarithromycin
Spectrum includes MAC,
Mycobacterium leprae, anaerobes
More active against gram +ve cocci,
Moraxella, Legionella, Mycoplasma
pneumoniae, Helicobacter pylori
Active metabolite produced
Metabolised by saturation kinetics
Pseudomembranous
enterocolitis
Hepatic dysfunction
Drug interaction profile
similar to erythromycin
1. RTI, ENT infections,
atypical pneumonia
2. Skin infection due to Strep
pyogenes & Staph aureus
3. H. pylori
4. MAC in AIDS patients
5. Leprosy
Azithromycin
Expanded spectrum
Improved pharmacokinetics
Better gastric tolerance
↓ drug interaction
1. Legionnaire‘s pneumonia
2. Chlamydia trachomatis
3. RTI, ENT, skin, soft tissue
infections
4. Gonorrhoea, MAC
5. Potential uses typhoid,
toxoplasmosis, malaria
Roxithromycin
Long acting, acid stable
↓ G.I. intolerance, ↑ tissue
penetration
↓ drug interactions
Less active against B. pertussis
Uses- alternative to erythromycin for
RTI, ENT, skin, soft tissue & genital
tract infections
SAEID KASHEFI Page 47
42) Which of the macrolide antibiotics is free from drug-drug interaction? Explain. (2)
Because clarithromycin is metabolized by hepatic cytochrome P450 microsomal enzymes, it, like
erythromycin, has the potential to interact with other drugs.
However, clarithromycin is less potent P450 inhibitor than erythromycin.
Erythromycin inhibits hepatic oxidation of many drugs. The clinically significant interactions are-rise in plasma
levels of theophylline, Carbamazepine, valproate, ergotamine and warfarin.
Several cases of Q-T prolongation, serious ventricular arrhythmias and death have been reported due to inhibition
of CYP3A4 by erythromycin/clarithromycin resulting in high blood levels of concurrently administered
terfenadine/astemizole/cisapride.
Azithromycin is unlikely to interact with drugs metabolized via the hepatic cytochrome P450 enzyme system,
and few interactions have been reported clinically. Interaction with Theophylline, carbamazepine, warfarin,
terfenadine and cisapride are not likely.
43) Clindamycin-Erythromycin combination is unsuitable for antibacterial therapy? (1)
Cross resistance with other Macrolides, Clindamycin, Chloramphenicol
SAEID KASHEFI Page 48
Miscellaneous
Antibiotics
Lincosamide antibiotics*
1. Clindamycin
2. Lincomycin
Glycopeptide antibiotics
3. Vancomycin
4. Teicoplanin
Oxazolidinone
5. Linezolid*, Radezolide, Torezolide
Streptogramins (Pristinamycin)*
6. Quinupristin/Dalfopristin [KWIN-yoo-pris-tin/DAL-foh-pris-tin]
7.Mupirocin
8. Fusidic acid
9.Polypeptide antibiotics
9. Polymyxin B
10. Colistin
11. Bacitracin
12.Tyrothricin
SAEID KASHEFI Page 49
Pharmacokinetics Adverse effects Uses
Clindamycin
Lincosamide antibiotic
Mechanism of action–
similar to erythromycin-
Inhibits protein synthesis-
binding to 50S ribosomes
Spectrum:
Susceptible organisms
Gram +Ve cocci including
Staph
diphtheriae and Nocardia
Toxoplasma and B.
fragilis
Non-susceptible
organisms:
Gram –Ve bacilli
Good oral
absorption
Poor CSF
penetration
Good penetration
into Skeletal
muscles and soft
tissues
Accumulates in
macrophages
Abdominal pain
Diarrhoea
Pseudomembran
ous enterocolitis
(Suprainfection)
from C. difficile
(Treatment –
metronidazole /
vancomycin)
1) Doc for anaerobic and
mixed infections
2) Bone infections from
anaerobes
3) With Pyrimethamine
for toxoplasmosis in
AIDS patients
4) With Primaquine in P.
carinii infections
5) Topically for infected
acne vulgaris
6) Note: Erythromycin +
clindamycin:
Irrational
Lincomycin
From Streptomyces
lincolnensis
Inhibits protein synthesis,
bacteriostatic
Mainly against G +ve
o Staphylococci
o Pneumococci
o Streptococci
diphtheriae
Largely replaced by
clindamycin
Orally effective
Vancomycin
Glycopeptide obtained
from Streptococcus
orientalis
Mechanism:- Binds to
terminal dipeptide
sequence of
peptidoglycan unit
prevents its release from
carrier inhibits cell wall
synthesis, bactericidal
Spectrum:
MRSA, S. Viridans
Enterococci, Cl. difficile,
Neisseria, Diphtheria and
Clostridia
Resistance - Alteration of
dipeptide target
(Methicillin resistant
Staphylococcus aureus)
Water soluble &
stable
Poor oral
absorption,
Route of
administration:
I.V
Excretion:
Glomerular
filtration
Toxicities:
Oto and
Nephrotoxicities
(dose rated)
Hypotension &
‗Red man
syndrome‘ (rapid
i.v injection has
caused chills,
fever, urticaria and
intense flushing)
Skin allergy
Oral application:
Pseudomembranous
enterocolitis
Systemic uses:
1. MRSA
2. Substitute to
penicillin for
enterococcal
endocarditis
SAEID KASHEFI Page 50
Teicoplanin
Spectrum gram +ve organisms
Mechanism similar to vancomycin
Active against vancomycin resistant strains
also
SABE,
MRSA,
penicillin resistant
streptococcal infections
Linezolid
Binds to 23S ribosomal RNA of 50S ribosome.
Inhibits protein synthesis by preventing
formation of N- formyl methionine tRNA – 70s
initiation complex
Bacteriostatic
Spectrum MRSA, VRSA, VRE, penicillin
resistant Strep. pyogenes, Strep. viridans, Strep.
pneumoniae, C. diphtheriae, Listeria, Bact.
fragilis
Adverse Effects:
Candida
superinfection
Interactions:
It is a MAO
inhibitor
hypertensive
crisis with
tyramine & other
adrenergic drugs
Hospital acquired
infections
infections caused
by multidrug
resistant gram +ve
bacteria
Quinupristin
/Dalfopristin
a mixture of two streptogramins (B,A) in a ratio
of thirty to seventy, respectively.
-derived from a streptomycete and then
chemically modified.
-MOA-Each component of this combination drug
binds to a separate site on the 50S bacterial
ribosome, forming a stable ternary complex.
The drug is
normally reserved
for the treatment of
vancomycin-
resistant
Enterococcus
faecium (VRE)
Fusidic Acid Steroidal
Narrow spectrum gram +ve
Inhibits protein synthesis
Used topically for cutaneous infections
Polymyxin B
& Colistin
Spectrum gram –ve
Cationic detergents
Bind to membrane phospholipids
pseudopore formation ↑ permeability
A/E: Kidney damage, neurological disturbance,
N-M blockade
1) Topically for skin
infections, otitis
externa, conjunctivitis,
corneal ulcer
2) Orally for gram –ve
bacillary diarrhea,
pseudomonas
superinfection
Bacitracin
Spectrum gram +ve bacteria, Neisseria, H.
influenzae
Inhibits cell wall synthesis
Used topically for infected wounds, ulcers
Bacitracin is not absorbed orally.
It is not used parenterally because of high toxicity to the kidney.
Tyrothricin Mixture of gramicidin & tyrocidin
↑ membrane permeability, uncouples
oxidative phosphorylation
Used topically
SAEID KASHEFI Page 51
Methenamine Converted to formaldehyde in acidic pH
Almost all bacteria are sensitive to free
formaldehyde
Urine can be acidified with hippuric acid,
mandelic acid
Methenamine + Mandelic acid
methenamine mandelate
Urea splitting organisms (proteus) ↑ urinary
pH ↓ formaldehyde formation
A/E: G.I. distress, painful & frequent
micturition, albuminuria, hematuria, rashes
Methenamine
mandelate
contraindicated in
renal & hepatic
insufficiency
Drug interaction :
Sulfonamides
Uses: Chronic
UTI, esp. due to
E.coli
Nitrofurantoin More active in acidic pH
Causes DNA damage, bacteriostatic
Effective against E.coli, enterococci
A/E: G.I. distress, hypersensitivity, liver
damage, megaloblastic anemia
Uses: UTI- prophylaxis & recurrent cases
Phenazopyrid
ine Analgesic
Symptomatic relief of burning sensation,
dysuria
Azo dye colors urine orange red
Treatment of UTI
Treatment of STD
SAEID KASHEFI Page 52
44) Uses and toxicities of vancomycin, MOA? (2)
Pharmacokinetics Adverse effects Uses
Vancomycin
Glycopeptide obtained
from Streptococcus
orientalis
Mechanism:- Binds to
terminal dipeptide
sequence of
peptidoglycan unit
prevents its release from
carrier inhibits cell wall
synthesis, bactericidal
Spectrum:
MRSA, S. Viridans
Enterococci, Cl. difficile,
Neisseria, Diphtheria and
Clostridia
Resistance - Alteration of
dipeptide target
(Methicillin resistant
Staphylococcus aureus)
Water soluble &
stable
Poor oral
absorption,
Route of
administration:
I.V
Excretion:
Glomerular
filtration
Toxicities:
Oto and
Nephrotoxicities
(dose rated)
Hypotension &
‗Red man
syndrome‘ (rapid
i.v injection has
caused chills,
fever, urticaria and
intense flushing)
Skin allergy
Oral application:
Pseudomembranous
enterocolitis
Systemic uses:
3. MRSA
4. Substitute to
penicillin for
enterococcal
endocarditis
SAEID KASHEFI Page 53
TB
SAEID KASHEFI Page 54
45) Classified anti-TB drugs with examples. MOA of any two first line anti-TB, rational behind the
multi-drug treatment of TB? (10)
46) Discuss the role of INH as a first line drug in the chemotherapy of TB? (4)
First Line
(Primary agents)
Second Line
(Reserved drugs)
Newer Drugs
High antitubercular efficacy and
low toxicity which are used
routinely.
1. Isoniazid (H)
2. Rifampin (R)
3. Pyrazinamide (Z)
4. Ethambutol (E)
5. Streptomycin (S)
- Low antitubercular efficacy
- or High toxicity or both
1. Cycloserine (Cys)
2. Para-aminosalicylic acid (PAS)
3. Kanamycin (Kmc)
4. Amikacin (Am)
5. Ethionamide (Etm)
6. Thiacetazone (Tzn)
7. Capreomycin (Cpr)
1. Ciprofloxacin
2. Ofloxacin
3. Clarithromycin
4. Azithromycin
5. Rifabutin
SAEID KASHEFI Page 55
Isoniazid (INH)
Rifampin Semisynthetic derivative of rifamycin-B obtained from
Streptomyces mediterranei
Mode of action: Rapid Tuberculocidal
Site of action: Intra and Extra cellular
Effective Media: Acidic and alkaline
Susceptible population:
Kills rapidly multiplying organisms
Inhibits quiescent organisms
Resistant organisms: A typical Mycobacteria
Mode of action: Tuberculocidal
Site of action: Intra and Extra cellular
Effective Media: Acidic and alkaline
Susceptible population:
Rapidly multiplying organisms
Spurters and slow growing
Quiescent organisms
Effective against many atypical Mycobacteria
Mechanis
ms of
action
Unknown, but the hypothesis includes effects
on lipids, nucleic acid and biosynthesis.
Primary action seems to inhibit the biosynthesis
of mycolic acids which are the unique fatty acid
component of mycobacterial cell wall.
INH has high selectivity for mycobacteria
The lipid content of mycobacteria exposed to
INH is reduced
A gene labeled with inh A which encodes for a
fatty acid syntheses enzyme is the likely target
of INH action
The sensitive mycobacteria concentrate INH
and convert it by a catalase peroxidase enzyme
into an active metabolite that appears to
interact with the inh A gene
Site of action: repo-B gene
Effect: Inhibits DNA-dependent RNA
polymerase enzymes‘ expression & thus can
block transcription (inhibits RNA synthesis)
Other susceptible organisms:
Gram +Ve (Strepto and Staphylococci)
and –Ve rods (H. influenzae, Proteus, E.
coli, Pseudomonas)
M. leprae
Pharmaco
kinetics
About 75-95% of a dose is excreted in the urine
in 24 hr.
State: As a metabolite.
The excretory product: Acetyl-isoniazid.
Pathway: Enzymatic acetylation.
Note: Isoniazid metabolism is under genetic
control. There are 2 groups of people. Fast and
slow acetylators
Fast acetylators: Those that have high acetyl
transferase activity. May produce more toxic
(hepatotoxicity) intermediate. t 1/2 will be about
1 hours
Slow acetylators: Those that have slow acetyl
transferase activity. t 1/2 will be about 3 hours
(chances of drug interaction)
Ethnicity: Eskimos, Native American Indians,
and Asians are fast acetylators
Absorption: Excellent following PO
Distribution: Well penetration into caseous
masses, CSF, Placental and other body fluids
Metabolism: Deacylation into an active drug
Elimination: Rapidly eliminated in the bile
and reabsorbed (enterohepatic circulation).
Half-life: 6 hours.
SAEID KASHEFI Page 56
Drug Interaction
Aluminium hydroxide inhibits INH absorption
INH inhibits Phenytoin, Carbamazepine,
Diazepam and Warfarin metabolism (rise their
blood levels)
PAS inhibits INH metabolism and prolongs its
duration of action
Rifampin does induce microsomal drug
metabolizing enzymes
Consequences:
1. Increases its own metabolism
2. Decreases the half-life of some other drugs
(eg., Phenytoin, digitoxin)
3. Causes failure of contraception if given
with OCs
Adverse
Effects
Hepatitis
more frequent in fast acetylators and
alcoholics
Age-dependent, aged are at high risk
Peripheral neuritis:
Paresthesia, Numbness, Mental
disturbances and convulsions
Pyridoxine (vitB6) (10mg/day) to overcome
this
Allergic reactions
Rashes
Fever
aches
Serious: (preclude drug-continuation)
Hepatitis
Respiratory syndrome
Less serious:
G.I. Syndrome: Anorexia, Nausea
,Vomiting Mild abdominal pain
Flu syndrome: Fever, Skin Eruptions,
Rash, Pruritis
Cutaneous syndrome
Note: Imparts red orange color to fluids
Therapeutic
applications
In TB therapy
In the therapy of Leprosy
Against meningitis (treatment and
eradication) from H. influenzae and
meningococcal
For methicillin resistant staphylococci
With doxycycline in brucellosis
47) Explain the pharmacological basis for the INH with Pyridoxine in TB therapy? (1)
INH is well tolerated by most patients. Peripheral neuritis and a variety of neurological manifestations
(paresthesias, numbness, mental disturbances, rarely convulsions) are the most important dose-dependent toxic
effects.
These are due to interference with utilization of pyridoxine and its increased excretion in urine.
Pyridoxine given prophylactically (10 mg / day) prevents the neurotoxicity even with higher doses, but routine use
is not mandatory. INH neurotoxicity is treated by pyridoxine 100 mg/day.
Due to formation of Hydrazone, the renal excretion of pyridoxine compounds is increased. Thus, isoniazid therapy
produces a pyridoxine deficiency state.
SAEID KASHEFI Page 57
48) Ethambutol should not be prescribed for children. Why? (2)
Loss of visual acuity/color vision
Because young children may be unable to report early visual impairment, it should not be used below 6 years of
age.
49) Describe the short course therapy of TB, explaining the rational antitubercular drugs? (4)
50) Rational behind combining 4 first line drugs for the initial therapy of TB? (2)
Short course therapy of TB
Duration: 6 – 9 Months
Initial intensive phase Continuation Phase
Duration: 2 – 3 months
Drugs: H, E, R, Z or S
Why this?
For rapid killing of the TB bacilli
For sputum conversion
For symptomatic relief
Duration: 4 – 6 months
Drugs: H, R and E (in a few cases)
Objectives:
To eliminate the residual bacilli
To prevent the relapse
Summary: Rationale of drug-combinations
To prevent emergence of resistance
To obtain maximum synergism
To enhance pts compliance (OD)
Quick relief form symptoms
To make Pt non-contagious
To prevent relapse
To eradicate the disease
SAEID KASHEFI Page 58
Leprosy
SAEID KASHEFI Page 59
51) Why is multi-drug therapy followed for leprosy treatment? (2)
1) Effective in dapsone resistance cases
2) Prevents emergence of dapsone resistance
3) Affords quick symptomatic relief
4) Makes Multibacillary non-contagious
5) Prevents relapses
6) Reduces total duration of therapy
52) Lepra reaction and drugs used to treat it? (2)
Reaction in Leprosy
Treatment of Lepra reaction : Drugs
Lepra
reaction
– Occurs in lepromatous leprosy
– Two types:
1) Jarish Herxheimer type reaction
Life threatening
Erythema Nodosum Leprosum
2) Sulfone syndrome:
Fever, Malaise, Jaundice, anaemia, Lymph node enlargement
Clofazimine
Chloroquine
Thalidomide
Corticosteroids
Reversal
Reaction
– Seen in Tuberculoid Leprosy – Delayed hypersensitivity type – Skin Ulceration – Multiple nerve involvement – Sudden occurrences
Clofazimine or
Corticosteroids
Lepra reaction: Type-I
During Dapsone therapy for leparamatous leprosy some reactive episodes may occur. These are known as
Lepra reaction.
These are of two types. Type-I Lepra reaction are also known as reversal reaction.
There are delayed hypersensitivity reactions to M. Leprae antigens (Type IV hypersensitivity).
It is characterized by cutaneous ulcerating and multiple nerve involvement.
It can also be seen during dapsone therapy for tuberculoid leprosy.
Prompt treatment with corticosteroids is necessary to prevent nerve damage.
Lepra reaction: Type –II
Also known as erythema nodosum leprosum, represent a humoral antibody response (Type-III
hypersensitivity) to dead bacteria.
Lepra reaction is of abrupt onset, existing lesions enlarge, become red, inflamed and painful.
This reaction can be treated with clofazimine or corticosteroid or thalidomide.
If Lepra reaction relapse 1-2 months after dapsone use, it is called ―Sulfone syndrome‖ this is characterized
by fever, lymph node enlargement, general malaise, jaundice and anaemia
SAEID KASHEFI Page 60
Antiviral
SAEID KASHEFI Page 61
72) Classify antiviral drugs and mechanism of any 2 which are effective against DNA-virus at
different stages? (10)
Classification
Drugs
Anti-Herpes
simplex virus
Acyclovir, Idoxuridine, Famciclovir, Ganciclovir, Foscarnet
Anti-Retrovirus
(3)
Entry
inhibitors
Nucleoside reverse
transcriptase inhibitors
(NRTIs)
Non-nucleoside reverse
transcriptase inhibitors
(NNRTIs)
Protease inhibitors
Enfuvirtide
Zidovudine (AZT)
Lamivudine
Didanosine
Zalcitabine
Stavudine
Abacavir
Nevirapine
Efavirapine
Efavirenz
Delavirdine
Ritonavir
Indinavir
Saquinavir
Amprenavir
Lopinavir
Anti-Influenza
virus
Amantadine
Rimantadine
Nonselective
Antiviral Drugs
Lamivudine,
Ribavirin,
Interferon α
Steps for Viral Replication
1) Adsorption and penetration into cell
2) Un-coating of viral nucleic acid
3) Synthesis of regulatory proteins
4) Synthesis of RNA or DNA
5) Synthesis of structural proteins
6) Assembly of viral particles
7) Release from host cell
SAEID KASHEFI Page 62
Anti-Herpes virus
Herpes viruses 2 type:- Herpes simplex type I and II
1) Type I cause disease of mouth, face & skin
2) Type II affects genitals, rectum and skin
Vidarabine- 1st agent to be developed, Too toxic
Idoxuridine, Acyclovir, Famciclovir, Ganciclovir, Foscarnet
Antiviral Agents
1) Acyclovir- prototype
2) Valacyclovir
3) Famciclovir
4) Penciclovir
5) Trifluridine
6) Vidarabine
MOA (Acyclovir)
It is an acyclic guanosine derivative
Selectively pickup by viral infected cell
Phosphorylated by viral thymidine kinase to Di- and tri-phosphorylated by host cellular enzymes
It Inhibits viral DNA synthesis by:
1) competing with dGTP for viral DNA polymerase
2) chain termination
Mechanism of Resistance Acyclovir
Alteration in viral thymidine kinase and viral DNA polymerase
Cross-resistance with valacyclovir, famciclovir, and ganciclovir
Uses
Herpes Simplex Virus 1 and 2(HSV)
Varicella-zoster virus (VZV)
Side Effects:
Nausea, diarrhea, headache, tremors, skin rash and delirium
Drug Interaction
SAEID KASHEFI Page 63
73) Write briefly on interferons as antiviral agents? (5)
What are interferons?
A family of inducible proteins synthesized y mammalian cells as part of immune system
Types of interferons:
1) Interferon -α (used in hepatitis B and C and in cancer)
2) Interferon-β (used in multiple sclerosis)
3) Interferon- γ (used in chronic granulomatous disease)
Mechanism of action:
Activate the cytokine receptors of the host cell to transcribe interferon induced protein (IIP)
Induction of the production of enzyme such as :
1) Protein kinase
2) Oligoisoadenyl synthetase
3) PDE
Result: inhibition of the translation of viral-mRNA
Antiviral actions:
Broad spectrum anti-viral agent
Inhibit the viral replication by interfering into all major steps of replications
Adverse effects:
Allergic effect: alopesia, flu syndrome
Neurotoxicity: tremors, sleepiness
Myelosuppression: dose related effect
CVS effect: hypotension, cardiac arrhythmia
Thyroid dysfunction
Uses:
To prevent the reaction of HSV
INF α-2a is used for croninc hepatitis B
INF α-2b is used fo hepatitis C
SAEID KASHEFI Page 64
74) Mechanism of HIV replication in host, MOA of anti-HIV drugs? (8)
Anti-
Retrovirus
(3)
Entry
inhibitors
Nucleoside
reverse transcriptase
inhibitors
(NRTIs)
Non-nucleoside
reverse transcriptase
inhibitors
(NNRTIs)
Protease inhibitors
Enfuvirtide
Zidovudine (AZT),
Lamivudine
Didanosine
Zalcitabine
Stavudine
Abacavir
Nevirapine
Efavirapine
Efavirenz
Delavirdine
Ritonavir
Indinavir
Saquinavir
Amprenavir
Lopinavir
SAEID KASHEFI Page 65
Reverse Transcriptase Inhibitors
Mechanism of
Action
Side Effects Mechanism
of
Resistance
Clinical Uses
Entry
inhibitors
Enfuvirtide
NRTIs
Zidovudine
(AZT)
Lamivudine
Didanosine
Zalcitabine
Stavudine
Abacavir
MOA of Zidovudine (AZT)
A deoxythymidine analog, enters the cell via passive diffusion,
it must be converted to the triphosphate form by mammalian thymidine kinase, then competitively inhibits deoxythymidine triphosphate for the reverse transcriptase enzyme, causes chain termination
Myelosuppression, including anemia and neutropenia
GI intolerance, headaches, myalgia and insomnia common at the start of therapy
Myopathy, lactic acidosis, hepatomegaly, convulsions and encephalopathy are infrequent.
Due to mutations in the reverse transcriptase gene
more frequent after prolong therapy and in persons
Available in IV and oral formulations
activity against HIV-1, HIV-2, and human T cell lymphotropic viruses
mainly used for treatment of HIV, decreases rate of progression and prolongs survival
prevents mother to newborn transmission of HIV
NNRTIs
Nevirapine
Delavirdine
Efavirenz
Bind to site on viral reverse transcriptase, different from NRTIs, this results in blockade of RNA and DNA dependent DNA polymerase activity
do not compete with nucleoside triphosphates do not require phosphorylation these drugs cannot be given alone substrates and inhibitors of CYP3A4
Nevirapine- prevents transmission of HIV from mother to newborn when given at onset of labor and to the neonate at delivery
Delavirdine- teratogenic, therefore cannot be given during pregnancy Efavirenz- teratogenic, therefore cannot be given during pregnancy
Protease
Inhibitors
The protease enzyme cleaves precursor molecules to produce mature, infectious virions
these agents inhibit protease and prevent the spread of infection
These agents cause a syndrome of altered body fat distribution, insulin resistance, and hyperlipidemia
Diarrhea
Nausea
Fatigue
Headache
SAEID KASHEFI Page 66
75) Zidovudine plus Zalcitabine plus Indinavir in HIV therapy? (2)
Life-long therapy is required.
Minimum of 3 drugs
A triple-drug regimen consisting of two NRTIs and PI is recommended for percutaneous blood exposure.
2 NRTI‘S + NNRTI / PI.
SAEID KASHEFI Page 67
Antifungal
SAEID KASHEFI Page 68
53) Antifungal drugs- Classification (5)
54) Mention major topical anti-fungal drugs? (2)
AZOLES
Imidazoles Triazole
(Systemic) Topical Systemic
Clotrimazole,
Miconazole
Econazole
Ketoconazole Itraconazole
Fluconazole
Antibiotics Polyene antibiotics Heterocyclic benzofuran
Amphotericin B, (AMB)
Nystatin,
Hamycin
Natamycin
Griseofulvin
Antimetabolites 5-Fluorocytosine (5-FC)
Allylamine Terbinafine
Other topical
agents
Tolnaftate, Benzoic acid, Sod. Thiosulfate.Undecylenic acid, Quiniodochlor, Ciclopirox
olamine,
SAEID KASHEFI Page 69
55) MOA and uses of Amphetamine B and Mebendazole? (2)
MOA Drug interaction Uses
Amphotericin B
In fungi: Ergosterol in membranes:
higher affinity than mammalian
cholesterol for AMB
Ergosterol: Only present in fungal
cell membrane and not in animal
cell
Ergosterol: Polyenes combine
with it, get inserted into the
membrane and several molecules
together orient themselves and
form a micropore.
The hydrophilic side forms the
interior of the pore through which
ions, amino acids and other water
soluble substances move out
(leakage of cell contents)
The micropore is stabilized by
membrane sterols which fill up the
spaces b/n the AMB on the
lipophilic side
Alters cell permeability selectively
to K+ and Mg2+.
Synergism with:
Flucytosine
Rifampicin
Enhanced renal
toxicity:
Aminoglycosides
IV: Serious systemic
fungal infections
Topically for oral,
vaginal & cutaneous
candidiasis
Leishmaniasis: Reserve
drug for Kala azar
The drug of choice for:
Cryptococcal meningitis
Mucormycosis
(zygomycosis)
Invasive fungal infection,
not responding to other
therapy
Adverse effect
Acute: Infusion-related
Chills, fever, dyspnea,
nausea, vomiting,
bronchospasm,
hypotension,
convulsions
Chronic
Nephrotoxicity
azotemia, impaired
concentration, impaired
urinary acidification, K &
Mg wasting with
hypokalemia and
hypomagnesemia
Normochromic,
normocytic anemia,
↓ erythropoietin
Mebendazole
A broad spectrum anthelmintic.
It is poorly absorbed when given
orally.
It acts by binding to and interfering
with the synthesis of the parasite‘s
microtubules and by decreasing
the glucose uptake.
Affected parasites are expelled
with faces.
It is relatively free of toxic effects.
It is contraindicated in pregnancy,
because of its embroyotoxic and
teratogenic effects.
Cestodes (Tapeworms)
Nematodes
SAEID KASHEFI Page 70
56) Brief note on ketoconazole? (4)
In fungi, the cytochrome P450-enzyme lanosterol 14-a demethylase is responsible for the conversion of
lanosterol to ergosterol
Azoles bind to lanosterol 14a-demethylase inhibiting the production of ergosterol
Spectrum: yeasts and moulds - poor absorption limits its role for severe infections, generally used in
mucosal infections only
Pharmacokinetics
Variable oral absorption, dependent on pH (often given with cola or fruit juice)
T1/2 7-10 hours
Protein binding > 99%
Hepatic, bile and kidney elimination
H2 blockers, antacids--- decrease absorption
Hepatoxicity (2-8%), increase in transaminases, hepatitis
Dose related inhibition of CYP P450 responsible for testosterone synthesis
Dose-related inhibition of CYP P450 responsible for adrenal cortisol synthesis
Ketoconazole –Drug interactions
Hepatic enzyme inhibitors
Ketoconazole + Sulfonylureas
Ketoconazole + Phenytoin
Ketoconazole + Warfarin
Ketoconazole + Cyclosporine
Increase plasma levels
SAEID KASHEFI Page 71
57) Consequents of co-administration of ketoconazole and cisapride? (2)
The dangerous interaction with terfenadine, astemizole and cisapride resulting in polymorphic ventricular
tachycardia due to excessive rise in plasma levels of these drugs has resulted in withdrawal of these drugs from
the market in many countries.
SAEID KASHEFI Page 72
Anti-protozoal Anti-amebiosis
Anti-malaria
SAEID KASHEFI Page 73
58) Why is diloxanide furoate combined with tinidazole for amoebiasis? (2)
59) A course of Metronidazole treatment is often followed by treatment with Diloxanide. Give
reason? (2)
Diloxanide furoate
It is a highly effective luminal amoebicide: directly kills trophozoites responsible for production of cysts.
The furoate ester is hydrolyzed in intestine and the released diloxanide is largely absorbed.
Diloxanide is a weaker amoebicide than its furoate ester
No systemic antiamebic activity is evident despite its absorption.
Diloxanide furoate exerts no antibacterial action.
It is less effective in invasive amoebic dysentery, because of poor tissue amoebicidal action.
Side effects are flatulence, occasional nausea, itching and rarely urticaria. It is the drug of choice for mild
intestinal,/asymptomatic amoebiasis, and is given after any tissue amoebicide to eradicate cysts.
Combined use with metronidazole/ tinidazole is quite popular.
60) Adverse effects and uses of emetine? (2)
Adverse effect Uses
Emetine and
Dehydroemetine
Emetine is an alkaloid, DHE-
semisynthetic
They are irritant, bitter in taste and nauseating---- Emetine cannot be given orally because it will be emitted out It is administered by s.c. or i.m injection: only i.m route
Kill tissue trophozoites and
have no effect on cysts
DHE is less toxic than
emetine
60 mg once daily for 5 days
Emesis (vomiting)-due to
the stimulation of CTZ
Muscle weakness and
stiffness
ECG changes- T-wave
inversion and prolongation
of PR interval
Tachycardia, hypotension
and cardiac arrhythmias
Itching and skin rashes
Nausea
Eczematoid lesions may
occur at the injection site
Tissue amoebicides
A) Intestinal and
Extraintestinal
Ameoebicides
Because of the drawbacks, emetine is now seldom used as a reserve drug in severe intestinal or extraintestinal amoebiasis, or for patients not responding to or not tolerating metronidazole
SAEID KASHEFI Page 74
61) Why should you abstain from alcohol during treatment with metronidazole? (2)
Interactions: A disulfiram-like intolerance to alcohol occurs in some patients taking metronidazole; they
should be instructed to avoid drinking.
Enzyme inducers (phenobarbitone, rifampin) may reduce its therapeutic effect.
Cimetidine can reduce metronidazole metabolism: its dose may need to be decreased.
Metronidazole enhances warfarin action by inhibiting its metabolism. It can decrease renal elimination of
lithium.
SAEID KASHEFI Page 75
Malaria
SAEID KASHEFI Page 76
62) Classify antimalarials with examples? (4)
4-Aminoquinoline
Chloroquine Amodiaquine
Active against all plasmodial species except p.falciparum Does not have effect on pre and exoerythrocytic phase –not given as
radical cure 1. Chloroquine is uncharged at neutral pH and hence diffuses freely into the parasite lysosome. 2. At the acidic pH of the lysosome, it is converted to a protonated membrane impermeable form, and is trapped inside the parasite. 3. Being a weak base, it gets concentrated in the acidic food vacuole of parasite, increases its pH and causes rapid clumping of pigment. 4. Chloroquine inhibits plasmodial heme polymerase (which converts toxic heme into nontoxic hemozoin) and forms toxic drug heme complex which damages the parasite
Quinoline-methanol
Mefloquine Mefloquine acts on the erythrocytic stage of the parasite. It forms toxic complex that damages membrane. It is given orally as it causes severe local irritation. Adverse effects: neuropsychiatric disturbances, visual and auditory
disturbances, teratogenicity and allergic reactions. Mefloquine is contraindicated in epilepsy, children below 2 years and
pregnancy. Is used as an alternate agent for multidrug resistant malaria. In addition, it is preferred for chemoprophylaxis of malaria.
Cinchona alkaloid
Quinine Quinine is highly effective against all the four species of plasmodium but not active for liver hypnozoite and sporozoite.
It has irritant action and causes myocardial depression MOA- like chloroquine
Biguanides
Proguanil Proguanil is a slow acting erythrocytic schizonticide Proguanil's antimalarial action is due to its conversion into the active
metabolite, cycloguanil. Cycloguanil inhibits plasmodial dihydrofolate reductase. Thus, proguanil inhibits tetrahydrofolate synthesis.
Diamino-pyrimidines
Pyrimethamine A diamino-pyrimidine that acts slowly on the erythrocytic forms of the parasite and inhibits plasmodial dihydrofolate reductase.
It is used as a slow acting agent.
With sulfadoxine, used in the acute attack of chloroquine resistant malaria Used in the chemoprophylaxis of malaria.
8-Aminoquinoline
Primaquine, Bulaquine
Primaquine is effective against vivax (hypnozoites), pre-erythrocytic and sexual forms of all species
It is converted into electrophiles, which act as oxidation reduction mediators and generate reactive oxygen species or interfere with the electron transport chain of parasite.
Sulfonamides and Sulfone
Sulfadoxine Dapsone
Tetracyclines Tetracycline Doxycycline
Tetracycline is Weak erythrocytic schizontocide Use: with quinine or Pyrimethamine+sulfonamide for treatment of
Chloroquine resistant malaria
Sesquiterpine lactones (Artemisinin derivatives)
Artesunate Artemether Artemether
Artemisinin: active principle form Artemisia annua Prodrug----dihydroartemisin Active against P. falciparum Potent and rapidly acting erythrocytic schizontocide
Mannich Base Pyronaridine
Phenanthrene Halofantrine
Napthoquinone Atovaquone
SAEID KASHEFI Page 77
63) Neat labeled diagram of life cycle of malaria parasite, explain its various stages and drugs
affecting them. MOA of quinine and adverse effects? (6+4+2)
Life cycle of the Malarial Parasite
1) Pre- or exoerythrocytic cycle in liver
2) Erythrocytic cycle in blood
3) Sporozoite
4) Merozoite
5) Trophozoite
6) Schizont
7) Gametocytes
(M-microgamatocytes, F-macrogamatocytes)
8) Hypnozoite
9) Haemozoin-malarial pigment
SMTSGHH
SAEID KASHEFI Page 78
Against
Pre-erythrocytic
schizogony
Against
Exo-erythrocytic
schizogony (V)
Against
Erythrocytic
schizogony
Against
Gametes
Proguanil (F + V)
Primaquine (F + V)
Tetracyclines (F)
Pyrimethamine
Primaquine
Chloroquine
Pyrimethamine
Primaquine
Quinine
Proguanil
Mefloquine
Mepacrine
Sulfonamides
Tetracyclines
Artemisinin
Halofantrine
Atovaquone
Chloroquine (V)
Mepacrine (V)
Quinine (V)
Primaquine (F + V)
Artemisinin (F + V)
Proguanil (F + V)*
Pyrimethamine (F + V)*
SAEID KASHEFI Page 79
64) Mechanism and uses of chloroquine? (4)
MOA:
1. Chloroquine is uncharged at neutral pH and hence diffuses freely into the parasite lysosome.
2. At the acidic pH of the lysosome, it is converted to a protonated membrane impermeable form, and is trapped
inside the parasite.
3. Being a weak base, it gets concentrated in the acidic food vacuole of parasite, increases its pH and causes
rapid clumping of pigment.
4. Chloroquine inhibits plasmodial heme polymerase (which converts toxic heme into nontoxic hemozoin) and
forms toxic drug heme complex which damages the parasite
Adverse effects Contraindications Pharmacogenetics
Variation in Drug
response due to
enzyme deficiency
Uses
Safe drug - proper doses
CVS and CNS:
hypotension,
vasodilatation,
suppression of
myocardial function,
cardiac arrhythmia and
eventual cardiac arrest.
GI Intolerance,
headache, blurring of
vision,
High doses- leads to
irreversible retinopathy,
ototoxicity, toxic
myopathy, cardiopathy
and peripheral
neuropathy
Used cautiously in patients
with severe neurological,
gastrointestinal and blood
disorders
Not recommended for
patients with epilepsy,
myasthenia gravis and
glucose-6-phosphate
deficiency.
Not recommended for
patients with psoriasis and
other exfoliative skin
conditions.
Glucose -6-phosphate
dehydrogenase deficiency
American Blacks,
Mediterranes Jews, Middle
East and South East races
– deficient in G6PD
Responsible for supply of
NADP ---acts as cofactor
for glutathion reductase
NADP---oxidised
glutathion to reduced
gutathion-------convertes
Fe+++ to Fe++ in
hemoglobin---also stability
to RBC
Oxidising drugs
Primaquine, Sulfone,
nitrofurantoin----hemolytic
anaemia
Resistant strain is
suspected if the
patient does not
respond during the
second day of
treatment.
Malaria
Ameoebiasis-hepatic
Lepra reactions
A
R
Infectious
mononucleosis
Autoimmune disorder-
discoid lupus
erythematous (DLE)
SAEID KASHEFI Page 80
Quinine
Quinine is the alkaloid derived from the bark of Cinchona tree.
It is a traditional remedy for malaria since 1820
Quinidine, the dextrorotatory stereo-isomer of quinine, is as effective as quinine for falciparum malaria
Quinine is highly effective against all the four species of plasmodium but not active for liver hypnozoite and
sporozoite.
It has irritant action and causes myocardial depression
MOA- like chloroquine
Adverse effects
Cinchonism- Swetting, tinnitus, blurred vision, diarrhea, and cardiac arrhythmias.-high plasma level
Dizziness, headache and nausea.
Quinine causes insulin release from ß cells leading to hypoglycemia
Black water fever includes marked hemolysis, hemoglobinemia and hemoglobinuria in the settings of
therapy for malaria.
65) Rationale for the use of primaquine in vivax malaria? (2)
It is effective against vivax (hypnozoites), pre-erythrocytic and sexual forms of all species
Is a causal prophylactic for all species of malaria, but has not been used in mass programmes, because of its
toxic potential.
Primaquine and Artemisinin are gametocidal to all species of Plasmodia, while chloroquine and quinine are
active against vivax but not falciparum gametes.
Primaquine differs from all other available antimalarials in having a marked effect on primary as well as
secondary tissue phases of the malarial parasite. It is highly active against gametocytes and hypnozoite.
SAEID KASHEFI Page 81
66) MOA and adverse effects of primaquine? (6)
Radical cure and terminal prophylaxis of infections with P.vivax and P.ovale
It is effective against vivax (hypnozoites), pre-erythrocytic and sexual forms of all species
MOA:
It is converted into electrophiles, which act as oxidation reduction mediators and generate reactive oxygen
species or interfere with the electron transport chain of parasite.
It is effective against vivax (hypnozoites), pre-erythrocytic and sexual forms of all species
Radical Cure:
Drugs active against Exo/Hypnozoites
Aims to achieve complete eradication of parasite
Needed in vivax (relapsing malaria)
Primaquine 15mg/day for 2 weeks
(Primaquine 45mg+Chloroquine 300mg)/week for 8 weeks
SAEID KASHEFI Page 82
Anthelmintics
SAEID KASHEFI Page 83
67) Classify the anthelmintics?
68) MOA of pyrantel pamoate and niclosamide and uses? (2)
drugs
Cestodes (Tapeworms)
(Tape: beef, pork,
fish, dwarf worm)
Mebendazole
Niclosamide
Chloroquine
Praziquantel
Cestodes have a flat, segmented body and they attach to the
host‘s intestine.
They lack a mouth and a digestive tract through their life
cycle.
Infestation by tapeworms or cestodes is transmitted by
ingestion of infected beef or pork.
So thorough cooking
Nematodes (Round Worms)
(Round: hook, whip, thread, pin, filaria, guinea worms)
Mebendazole
Piperazine
Pyrantel Pamoate
Levamisole
Albendazole
Ascariasis is the infection of the intestinal tract by the roundworm.
Symptoms: nausea, abdominal pain and cough. Live worms are passed through stool or vomit.
Nematodes are transmitted through the faecal – oral route, or by fingers contaminated by soil seeded with the eggs of the round worm.
Trematodes (flukes: blood, lungs, intestinal)
praziquantel
SAEID KASHEFI Page 84
Mechanism of action Uses
Mebendazole
A broad spectrum anthelmintic.
It is poorly absorbed when given orally.
It acts by binding to and interfering with the synthesis of the parasite‘s
microtubules and by decreasing the glucose uptake.
Affected parasites are expelled with faeces.
It is relatively free of toxic effects.
It is contraindicated in pregnancy, because of its embroyotoxic and
teratogenic effects.
Cestodes (Tapeworms)
Nematodes
Niclosamide
Vermicidal drug for all varieties of taeniasis.
Inhibits anaerobic phosphorylation of ADP of the parasite
To prevent digestion of segments and liberation of ova, it is mandatory to use a purge within 1-2 hours after the drug is administered.
Cestodes (Tapeworms)
praziquantel
Causes strong muscular contractions, thereby forcing the worm to detach from the wall of the vein.
Rapidly absorbed orally Excreted within 24 hours. Adverse effects : anorexia, drowsiness and allergic reactions
Tapeworm
Pyrantel
pamoate
acts as a depolarizing neuromuscular blocking agent, causing persistent activation of nicotinic receptors
Which leads to spastic paralysis of the worms
The adverse effects of the drug are mild
Nematodes (Round
Worms)
Piperazine
Piperazine competitively blocks the acetylcholine-produced
contractions of the ascaris muscle.
This leads to flaccid paralysis of the worms, due to which they are easily
expelled out by intestinal peristaltic movements.
The drug has a wide margin of safety
Adverse reactions: diarrhoea and urticaria.
Nematodes
Levamisole
causes sustained contracture of somatic muscles of the worm by
an irreversible,
non-competitive,
depolarization type of neuromuscular block
resulting in paralysis of the worm
Nematodes
SAEID KASHEFI Page 85
69) What is DEC? How is it useful in filariasis? (2)
Drug Therapy of Filariasis
Filarial infections are caused by tissue dwelling filarial nematodes, which are transmitted by the bites of
insects such as mosquito, blackfly and being fly.
Drugs for filarial infection:
Diethylcarbamazine citrate (DEC) Ivermectin
Diethylcarbamazine
Has a highly selective effect on microfilariae (Mf).
Leads to the rapid disappearance of microfilariae of Wuchereria bancrofti, Brugia malayi and
loa loa from the human peripheral blood.
Diethylcarbamazine sensitizes the microfilaria and entraps them in the reticuloendothelial system.
Thereby, it enhances phagocytosis and killing of the microfilaria.
Diethylcarbamazine also enhances cell mediated immunity of human hosts and thus their resistance to the
infestation.
Diethylcarbamazine is rapidly adsorbed from the gastrointestinal tract.
The products are eliminated within 30 hours.
Diethylcarbamazine causes fever, lymphadenopathy, muscular pain, tachycardia and skin rashes.
It also causes allergic reactions, which are sometimes severe.
Hence, it is recommended to start therapy with a small dose and then increase it gradually.
70) MOA of Mebendazole. List its uses and adverse effects? (4)
A broad spectrum anthelmintic.
It is poorly absorbed when given orally.
MOA:
It acts by binding to and interfering with the synthesis of the parasite‘s microtubules and by decreasing the glucose uptake.
Affected parasites are expelled with faeces.
Uses:
Nematodes (Round Worms)
Adverse effect:
It is relatively free of toxic effects.
It is contraindicated in pregnancy, because of its embroyotoxic and teratogenic effects.
71) Write briefly on Albendazole as anthelmintic? (2)
Is effective against many common intestinal worms in a single dose.
The drug is well tolerated
Albendazole and thiabendazole are effective in treating larva migrans.
SAEID KASHEFI Page 86
Anticancer
SAEID KASHEFI Page 87
72) Classify anticancer drugs based on MOA short note on their adverse effects? (6+4)
73) Adverse effects of anti-cancer drugs? (5)
A. Drugs acting directly on cells (Cytotoxic drugs)
Alkylating agents
Nitrogen-mustards
Cyclophosphamide Chlorambucil Mechlorethamine (MustineHCl) Ifosfamide Melphalan
Ethylenimine Thio-TEPA
Alkyl-sulfonate Busulfan
Nitrosoureas Carmustine (BCNU) Lomustine(CCNU)
Triazine Triazine Dacarbazine (DTIC)
Platinum-containing drugs
Cisplatin Carboplatin
Antimetabolites
Folate antagonist Methotrexate (Mtx)
Purine antagonist 6-MercaPtoPurine (5-MP) 6-Thioguanine (6-TG) Azathioprine Fludarabine
Pyrimidine antagonist S-Fluorouracil (5-FU) Cytarabine
Natural products
Vinca alkaloids Vincristine (Oncovin) Vinblastine
Taxanes Paclitaxel, Docetaxel
Epipodophyllotoxin
Etoposide
Camptothecin analogues
Topotecan Irinotecan
Antibiotics
Actinomycin D (Dactinomycin) Doxorubicin Daunorubicin (Rubidomycin) Mitoxantrone Bleomycin,
Mitomycin C
Miscellaneous
Hydroxyurea Procarbazine L-Asparaginase Imatinib
SAEID KASHEFI Page 88
B. Drugs altering hormonal milieu
Glucocorticoids Prednisolone and others
Estrogens Fosfestrol Ethinylestradiol
Selective estrogen receptor modulators Tamoxifen Toremifene
Selective estrogen receptor down regulators Fulvestrant
Aromatase inhibitors
Anastrozole Exemestane Letrozole
Antiandrogen Flutamide Bicalutamide
5-α reductase inhibitor Finasteride Dutasteride
GnRH analogues
Nafarelin Triptorelin
Progestins Hydroxyprogesterone Acetate etc.
GENERAL TOXICITY OF CYTOTOXIC DRUGS Majority of the cytotoxic drugs have more profound effect on rapidly multiplying cells, because the most important
target of action are the nucleic acids and their precursors; rapid nucleic acid synthesis occurs during cell division'
Many cancers (especially large solid tumours) have a lower growth fraction (lower percentage of cells are in
division) than normal bone marrow epithelial linings, reticuloendothelial (RE) system and gonads. These tissues
are particularly affected in a dose-dependent manner by majority of drugs; though, there are differences in
susceptibility to individual members.
1. Bone marrow
Depression of bone marrow results in granulocytopenia, agranulocytosis, thrombocytopenia, aplastic anaemia.
This is the most serious toxicity; often limits the dose that can be employed. Infections and bleeding are the usual
complications.
2. Foetus
Practically all cytotoxic drugs given to pregnant women profoundly damage the developing Foetus abortion,
fetal death, and teratogenesis.
3- Skin
Alopecia occurs due to damage to the cells in hair follicles. Dermatitis is another complication.
4. Gonads
Inhibition of gonadal cells causes oligozoospermia and impotence in males; inhibition of ovulation and
amenorrhoea are common in females.
Damage to the germinal cells may result in mutagenesis.
SAEID KASHEFI Page 89
5-Lymphoreticular tissues
Lymphocytopenia and inhibition of lymphocyte function results in suppression of cell mediated as well as humoral
immunity.
Because of action (1) and (2) + damage to epithelial surfaces, the host defence mechanisms (specific as well as
nonspecific) are broken down susceptibility to all infections is increased. Of particular importance are the
opportunistic infections due to low pathogenicity organisms Infections by fungi (Candida and others causing deep
mycosis), viruses (Herpes zoster, cytomegalo virus), Pneumocystis jiroveci (a fungus) and Toxoplasma re seen
primarily in patients treated with anticancer drugs.
6- Oral cavity:
The oral mucosa is particularly susceptible to cytotoxic drugs because of high epithelial cell turnover. Many
chemotherapeutic drugs produce stomatitis as an early manifestation of toxicity. The gums and oral mucosa are
regularly subjected to minor trauma, and breaches are common during chewing. Oral microflora is large and can
be the source of infection. Neutropenia and depression of immunity caused by the drug indirectly increase re
chances of oral infections. Thrombocytopenia may cause bleeding gums. Xerostomia due to the drug may cause
rapid progression of dental caries.
7- GIT
Diarrhoea, shedding of mucosa, hemorrhages occurs due to decrease in the rate of renewal of the mucous lining.
Drugs that frequently cause mucositis are-bleomycin, actinomycin D, daunorubicin, doxorubicin, fluorouracil and
methotrexate.
Nausea and vomiting are prominent with many cytotoxic drugs. This is due to direct stimulation of CTZ by the drug
as well as generation of emetic impulses/mediators from the upper g.i.t. and other areas.
8. Carcinogenicity
Secondary cancers, especially leukemias, lymphomas and Histiocytic tumours appear with greater frequency
many years after the use of cytotoxic drugs. This may be due to depression of cell mediated and humoral blocking
factors against neoplasia.
9. Hyperuricemia
This is secondary to massive cell destruction (uric acid is a product of purine metabolism). Gout and urate stones
in the urinary tract may develop. Allopurinol is protective by decreasing uric acid synthesis. In addition to these
general toxicities, individual drugs may produce specific adverse effects, e.g. neuropathy by vincristine,
cardiomyopathy by doxorubicin, cystitis and alopecia by cyclophosphamide.
SAEID KASHEFI Page 90
74) Mechanism of alkylating and their adverse effects? (5)
ALKYLATING AGENTS
These compounds produce highly reactive carbonium ion intermediates which transfer alkyl groups to cellular
macromolecules by forming covalent bonds.
The position 7 of guanine residues in DNA is especially susceptible, but other molecular sites are also involved.
Alkylation results in cross linking/abnormal base pairing/ scission of DNA strand. Cross linking of nucleic acids with
proteins can also take place.
Alkylating agents have cytotoxic and radiomimetic (like ionizing radiation) actions. Many are cell cycle non-specific,
i.e. act on dividing as well as resting cells. Some have CNS stimulant and cholinergic properties.
Adverse effect:
1. Depress bone morrow
2. GI disturbance
3. Depression of gametogenesis in male
SAEID KASHEFI Page 91
75) Give examples MOA of cyclophosphamide use, adverse effect? (6)
Cyclophosphamide
It is inactive as such: produces few acute effects and is not locally damaging.
It‘s activated in liver by CYP450
Transformation into active metabolites (aldophosphamide, phosphoramide mustard) occurs in the liver, and
a wide range of antitumour actions is exerted.
Uses:
It has prominent immunosuppressant property.
Thus, it is one of the most popular anticancer drugs.
Breast cancer, ovarian cancer, non-Hodgkin's lymphoma, CLL, soft tissue sarcoma, neuroblastoma,
Wilms' tumor, rhabdomyosarcoma
Adverse effect:
It is less damaging to platelets, but alopecia and cystitis (due to another metabolite acrolein) are
prominent. Chloramphenicol retards the metabolism of cyclophosphamide.
76) Use of MESNA in cyclophosphamide toxicity? (2)
Mercapto-ethane-sulfonate (mesna) "traps" acrolein released from cyclophosphamide and thus reduces the
incidence of hemorrhagic cystitis.
SAEID KASHEFI Page 92
77) Mechanism of action anti-cancer antibiotics? (4)
Mechanism of action
Many of these antibiotics bind to DNA through intercalation between specific bases and block the synthesis of
RNA, DNA, or both; cause DNA strand scission; and interfere with cell replication.
Drug Mechanism of Action Clinical Applications1 Acute Toxicity
Delayed Toxicity
Mitomycin
Acts as an alkylating agent and forms cross-links with DNA; formation of oxygen free radicals, which target DNA
Superficial bladder cancer, gastric cancer, breast cancer, non-small cell lung cancer, head and neck cancer (in combination with radiotherapy)
Nausea and vomiting
Myelosuppression, mucositis, anorexia and fatigue, hemolytic-uremic syndrome
Antibiotics
Actinomycin D (Dactinomycin) Doxorubicin Daunorubicin (Rubidomycin) Mitoxantrone Bleomycin,
Mitomycin C